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Abstract

Investigating the Role and Regulation of Alternative Polyadenylation in the DNA Damage
Response
By
Michael Robert Murphy

Advisor: Dr Frida Esther Kleiman

Cellular homeostasis is achieved by the dynamic flux in gene expression. Post-transcriptional
regulation of coding and non-coding RNA offers a fast method of adapting to a changing cellular
environment,

including

deadenylation,

microRNA

(miRNA)

pathway,

and

alternative

polyadenylation (APA). In this dissertation, I explored some of the mechanisms involved in the
post-transcriptional regulation of gene expression. The main hypothesis in these studies is that
a single APA event after DNA damage is governed by specific conditions and factors outside of
current known regulators of APA, and that the resultant transcript has a role in the DNA damage
response (DDR). My aims were a) to investigate the RNA processing and coding potential of a
CDKN1A APA transcript, b) to elucidate the conditions and factors involved during CDKN1A
APA induction, and c) to determine whether the CDKN1A APA transcript possess any biological
function.
In Chapter II, I investigated the miRNA-dependent recruitment of PARN nuclear
deadenylase to p53 mRNA 3’ untranslated region (3’UTR), as part of the regulatory feedback
loop involving PARN and p53. Then my studies focused on the function and regulation of APA
during the progression of DDR. Understanding the scope and impact of APA in different cellular
settings will help us to understand changes in the transcriptome and proteome and will offer
alternative avenues for specific and effective pharmaceutical design. In Chapter III, I present
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evidence of the magnitude of APA events occurring within introns during DDR, and the
mechanisms involved in the regulation of these intronic APA events. In Chapter IV, I further
investigate the coding potential and post-transcriptional processing of an intron-APA transcript
from the cyclin-dependent kinase inhibitor 1A (CDKN1A) gene, which encodes the cell cycle
arrest protein p21. Specifically, I observe that the CDKN1A intron-APA transcript has the
potential to be spliced from an alternative splice site, generating a ‘cryptic’ exon upstream of
intron-APA site, but also to exist as a non-spliced isoform. My results also indicate that neither
isoform is protein-coding, implicating the resultant transcripts are stable long non-coding RNAs.
In Chapter V, I characterized the CDKN1A intron-APA transcripts and analyzed the mechanisms
involved in their regulation, including the effect of both DNA binding proteins (p53) and RNA
binding proteins (HuR). Finally, in Chapter VI, I present evidence that far from being a byproduct of transcriptional control of canonical CDKN1A full-length mRNA, intron-APA transcripts
from CDKN1A gene play roles both in a non-stress and in DDR conditions, and also can alter
the timing of events during DDR. Thus, the data presented in this dissertation provides new
insights into the regulation of APA as well as the cellular roles that these events can participate.
This offers a greater understanding of DDR, which aids in clearly defining pathways during
therapeutic development for diseases, such as cancer.

v

Significance

Disruptions to normal homeostasis are constant events in a cell’s lifetime and come from
a variety of endogenous and exogenous sources. Many of these disruptions manifest as
damage to the nuclear DNA. While some of the lesions lead to synonymous mutations affecting
specific proteins, such as spontaneous base changes, many lead to more extensive alterations
such as double strand breaks and erroneous chromosomal fusions, or lesions that indirectly
interrupt cellular function by preventing processive transcription or replication. The cell
possesses several interconnected processes to respond to such preventive damages that
depend on the nature, duration and intensity of damage. The genetic and proteomic make-up of
the cell can also dictate functional output during DDR. There are mechanisms in place to
promote cell cycle arrest, programmed cell death, as well as transcriptional and posttranscriptional programs to produce a swift and global response to any perturbation. Some of
these post-transcriptional programs include both deadenylation of mRNA transcripts leading to
mRNA destabilization as well as APA due to recognition of alternative poly(A) signals within the
same transcriptional unit. Both events serve to alter the transcriptome and thus the proteome
and ultimately cellular function.
This dissertation characterizes some examples of these post-transcriptional events and
how they contribute to DDR. My studies indicate that alterations in RNA-protein complex
formation are part of a competition between two cooperative processes affecting RNA stability,
specifically the endonuclease Ago2 and the nuclear deadenylase PARN, which are components
of the microRNA and deadenylation machinery, respectively. Part of my studies showed that
sequence elements in the RNA are necessary for their recruitment. This study investigated
more closely how the 3’UTR of tumor suppressor TP53 mRNA acts as a docking station for
RNA regulators, helping to regulate mRNA levels and, thus, protein expression. This is relevant
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because it implicates RNA regulators affecting tumor suppressor pathways and hence
carcinogenesis. My findings lead to a broader understanding of the interplay of RNA regulatory
pathways following DNA damage.
The dynamic nature of mRNA 3’ end processing machinery allows the regulation of sites
of RNA cleavage and polyadenylation during transcription, APA, and hence transcriptome
composition having the potential to contribute to the cells rapid response to stress. It has been
shown that the splicing factor U1 snRNP is central to the regulation of APA in a concentrationdependent manner (Kaida et al. 2010; Berg et al. 2012). The presence of U1 snRNA prevents
the activation of cryptic promoter-proximal poly(A) sites, while the absence of U1 snRNA
permits their expression. While the papers referenced involved artificial manipulation of U1
snRNA levels, this dissertation demonstrates that promoter-proximal intron APA is activated as
a result of lowered U1 snRNA levels during DDR (Morra et al. 1986; Devany et al. 2016). As
many of the genes undergoing intronic APA during DDR are also identified as DDR genes, my
studies highlight that APA acts as both a consequence and cause of the response to cellular
stress.
While many of the components of the response to damage have been revealed, some
aspects remain understudied as new paradigms come to light, such as the functional roles of
RNAs both during stress and normal cellular homeostasis. My studies reveal some of the
characteristics of a gene undergoing intronic APA, CDKN1A, which encodes the global inhibitor
of cyclin-dependent kinases p21 (El Deiry et al. 1993). Importantly, my studies indicate that the
alternative transcript produced from CDKN1A intronic APA is a long non-coding RNA (lncRNA).
Evidence presented in this dissertation shows that this lncRNA from intronic APA events affects
the protein expression of the endogenous canonical product of CDKN1A, which in turn affects
cell proliferation. Understanding the complexity of the interplay between intronic APA events
and canonical gene products involved in DDR/tumor suppression, such as CDKN1A/p21, might
help us to understand cell-specific profiles, improving the development of new therapies and the
vii

identification of cancer subtypes. Although more work is necessary to identify the specific
mechanism involved in intronic APA isoforms-mediated regulation of protein expression, this
dissertation provides a valuable framework for understanding how APA events contribute to cell’
rapid response to DNA damage.
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CHAPTER I

BACKGROUND

1

Cleavage and Polyadenylation
Transcription termination in eukaryotic organisms is a highly conserved and coordinated
step marking the transition between transcription and RNA processing. In all mRNAs, except for
histones and long non-coding RNAs, transcription termination is demarcated from processive
RNA synthesis by the cleavage and polyadenylation (CpA) of the nascent RNA transcript. More
specifically, the newly transcribed precursor, which is complementary to the template DNA
strand from which it was blueprinted, is catalytically cleaved in the phosphate backbone leaving
a reactive 3’OH group. Once endonucleolytic cleavage has occurred, a long string of nontemplated adenosine residues are attached on the 3’ to denote the end of the transcript and
affect stability on the RNA. Without polyadenylation, the nascent RNA would be vulnerable to
degradation from 3’ exonucleases, leaving the message or catalytic activity the RNA had
evolved to transmit prevented in its function.
Polyadenylation is carried out by a family of nucleotidyltransferases and is conserved
across all 3 kingdoms of life (Anantharaman et al. 2002). Prokaryotes and archaea possess
either oligonucleotide adenylate tracks or a CCA motif, while over evolutionary time,
multicellular eukaryotes have adopted polyadenosine (polyA) tails into the hundreds of bases.
The enzyme responsible for the cleavage is also present across the kingdoms and is
remarkably conserved between yeast and mammals (Jenny et al. 1996). The universality of this
two-step coupled process highlights its importance in normal cellular homeostasis. Over billions
of years, the process has amassed a sizable repertoire of over 80 catalytic, structural,
activating, repressing, upstream and downstream components in mammalian cells (Shi et al.
2009); accounting for every normal and aberrant cellular condition. The core principle is detailed
in Figure 1.
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Figure 1: Schematic of the CpA process. 3’ end processing complexes (CPSF,
orange; CstF, green) are recruited to the DNA at the transcription bubble, and
recognize their respective sequences in the nascent transcript. The light blue
cleavage factors (CFs) aid in cleavage of the nascent RNA, allowing for poly(A)
polymerase (PAP) to catalyze the addition of adenosine nucleotides for poly(A)
binding (PAB) protein to bind to and protect the nascent RNA from degradation.
Taken from Elkon et al. 2013.

As it is understood today, CpA in humans occurs only in genes transcribed by the
holoenzyme RNA polymerase II (RNAP II). As RNAP II traverses a gene, initiating from the
promoter, the core complex and surrounding factors will encounter numerous DNA binding
proteins (DBPs), histone contexts, and sequence elements conferring information about the
immediate cellular environment, which will, in turn, affect the speed and frequency of
transcription. These contextual cues will also dictate where the nascent RNA transcript will end.
Canonically, this cue exists as the hexanucleotide AAUAAA, identified over 40 years ago
(Proudfoot and Brownlee 1976; Fitzgerald and Shenk 1981), which is necessary for CpA to
occur (Connelly and Manley 1988) but not for transcription to terminate (Zhang et al. 2015).
More recent analysis has shown this sequence to be the polyadenylation signal in ~50% of
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cases, as numerous other variants are utilized with decreased efficacy (Tian et al. 2005). As
shown in Figure 1, the complex responsible for recognition of the poly(A) signal is cleavage and
polyadenylation specificity factor (CPSF). While the subunit CPSF-160 directly binds to the RNA
at the poly(A) signal (Murthy and Manley 1995), subunit CPSF-73 contains the enzymatic
activity for endonucleolytic cleavage (Mandel et al. 2006) at the poly(A) site, several nucleotides
downstream of the poly(A) signal. Helping to coordinate the architecture of CpA machinery is
recognition of a GU-rich sequence downstream of the poly(A) site by the cleavage stimulation
factor (CstF) complex.
RNAP II has a conserved domain at its C-terminal end (C-terminal domain; CTD)
consisting of a heptad repeat in humans, which is subject to a number of modifications:
phosphorylation, peptidyl isomerization, and glycosylation (Bentley 2014). It is known that the
CTD is necessary for efficient CpA, partly through recruitment of CSPF and CstF components
(McCracken et al. 1997), which occurs in proximity to RNAP II localization sites throughout
transcribed genes, according to chromatin immunoprecipitation (ChIP) experiments (GloverCutter et al. 2008). It was also found that CPSF is required to induce polymerase pausing once
it encounters a functional poly(A) signal (Nag et al. 2007). These studies suggest that rather
than reside close by to the site of CpA, CstF and CPSF travel along with RNAP II during
nascent gene transcription in search of the poly(A) signal.
Other major components of the CpA machinery include cleavage factor (CF) required for
the cleavage reaction, CF IIm involved in the binding to RNAP II CTD and other CpA factors,
and poly(A) polymerase (PAP) involved in the addition of the adenosine tail. Since its discovery,
polyadenylation has been shown to be a vital part in controlling gene expression by affecting the
RNA’s lifespan, regulating its stability (Drummond et al. 1985; Bernstein et al. 1989),
translational efficiency (Gallie 1991), and export from the nucleus (Fuke and Ohno 2008). As the
presence or absence of a poly(A) regulates these processes, the length of a poly(A) tail can
itself be regulated for the same purposes (Eckmann et al. 2011). Thus, CpA is a highly
4

regulated and coordinated process whose regulatory signaling range between transcription
initiation and protein production.

Alternative Polyadenylation
As the primary signal for CpA is a hexanucleotide sequence, it is easy to predict that the
AAUAAA sequence can occur more than once per gene. Not including the effects of selection,
or repeat sequences such as microsatellites and long interspersed nuclear elements (LINES),
the probability of encountering one AAUAAA is 46 every 4096 bases. Assuming the human
genome has approximately 3 billion bases, there are 732,422 potential CpA sites, without even
taking into account functional variants of AAUAAA. While not every defined locus of the human
genome is characterized as a gene, transcription by RNAP II is pervasive (ENCODE Project
Consortium et al. 2007; Clark et al. 2011; Loya and Reines 2016), offering a wealth of
opportunity for novel functional transcripts.
Some of the earliest recorded alternative polyadenylation (APA) events fall into two
broad forms of APA: 3’ untranslated region (3’UTR) APA (Tosi et al. 1981) and coding region
APA (CR-APA) (Early et al. 1980) (Figure 2). Any mRNA produced is likely not only to possess
a coding sequence spread out over a number of exons, but also flanking non-coding regions, of
which the promoter proximal (5’UTR), at ~200 nt, is on average 5 times smaller than the ~1000
nt of the 3’UTR (Mignone et al. 2002). This difference in length provides the 3’UTR additional
chances to harbor extra poly(A) sites. But what advantage would more than one poly(A) site in
the 3’UTR convey? As poly(A) tails play a crucial role in RNA regulation, having more variation
in the signaling present in the 3’UTR offers more opportunities and a tighter post-transcriptional
regulation for any cellular context. For example, committing APA in a more upstream position
within the 3’UTR decreases the number of possible regulatory elements as well as alters RNA
secondary structure (Freire-Picos et al. 2001; Lamas-Maceiras et al. 2011). 3’UTR-APA in a
more upstream position results in an mRNA that has lost accessibility for regulatory factors such
5

as RNA binding proteins (RBPs) and RNAs with complementary base-pairing, such as, but not
restricted to, miRNAs, leading to a loss of either positive or negative regulatory effects. In sum,
the binding or lack thereof of regulatory signaling as a consequence of 3’UTR APA affects the
levels of the resultant mRNA, controlling not only protein expression levels but also protein
localization (Berkovits and Mayr 2015).

Figure 2: Variations of polyadenylation selection possible within protein coding
genes. Constitutive PA stands for genes with only one poly(A) site. In UTR-APA,
each alternative poly(A) site exists in the terminal exon. In CR-APA, the
alternative poly(A) site can reside in either an exon or intron upstream from the
terminal exon. Adapted from Rehfeld et al. 2013.
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The importance and scope of APA is exemplified by the close monitoring, widespread
data gathering and numerous all-encompassing perspectives being generated since the turn of
the decade (Di Giammartino et al. 2011; Lutz and Moreira 2011; Elkon et al. 2013; Tian and
Manley 2013, 2017). This flurry of insight is thanks in part to seminal papers using bioinformatic
analysis to investigate APA in mammalian cells (Tian et al. 2005; Yan and Marr 2005; Zhang et
al. 2005), which were able to address the frequency of APA occurrence and identify the players
in this complex regulatory network.
Some of the earliest attempts to investigate APA on a genome-wide scale involved
elucidating the position of termination sites in expressed sequence tags (ESTs) (Gautheret et al.
1998; Beaudoing et al. 2000), short cDNA sequences produced from clonal libraries, many of
which helped in gene discovery and mapping of the human genome (Adams et al. 1991). From
these studies, the extent of APA was estimated to occur in 20%-50% of transcription units. More
sophisticated bioinformatic approaches culminated in an agreed estimate of 50% of genes
possessing one or more poly(A) site. With enhancements in deep sequencing techniques that
number has expanded to 70-85% of genes (Ozsolak et al. 2010; Derti et al. 2012).
The implication of such an expansion in the number of potential transcripts from this
calculation should not be underestimated. Just as the impact RNA splicing had on proteomic
diversity and was recognized for such by the work of Roberts and Sharp in the 1993 Nobel Prize
in Physiology or Medicine (Sharp 1994), APA has similar functional outputs in its CR-APA form.
In contrast to 3’UTR-APA, which has multiple effects on mRNA or protein position and
abundance, CR-APA occurs anywhere upstream of the terminal exon and is capable of
producing an altered amino acid sequence (Figure 2). These differential termination sites have a
variety of end-products. APA can occur in an upstream intron; leading to either a) an extension
of the preceding exon and a novel C-terminal of the protein and/or 3’UTR (known as
composite), or b) the utilization of an alternative 3’ splicing site upstream of poly(A) signal
(known as skipped exon). APA can also be in an upstream exon resulting in a truncated protein.
7

In rare cases, APA can occur in the 5’UTR (Shen et al. 2008) resulting in either an alternative
start codon coupled with a small molecular weight protein, a small non-coding RNA, or an
unstable transcript. 5’UTR-APAs are rare because the transcripts are severely truncated and, in
many cases, nonfunctional with a small average size for CpA to occur. The production of shorter
transcripts from promoter-proximal poly(A) sites could represent a post-transcriptional
mechanism to downregulate the usage of the canonical poly(A). However, regulating gene
expression using this mechanism creates a potential cellular burden: what to do with the
resultant RNA?
The cell appears to be in the midst of its very own evolutionary arms race by having as
many ways to degrade aberrant RNA species as it does in creating them, thus striking a
balance between function and prevention of deleterious products. As I mentioned, transcription
is pervasive, and this includes bidirectional transcription from promoters (Seila et al. 2008) and
promoter-proximal termination (Szczepińska et al. 2015), both of which are negatively regulated
by exosome complex-mediated exonucleolytic activity (Preker et al. 2008) and downregulation
of transcription (Andersen et al. 2012). What complicates matters are that both types of these
transcripts are 5’ capped and 3’ (poly) adenylated and thus are inherently stable prior to
exosome complex detection. Notably, exosome-mediated degradation of these transcripts is not
universal across conditions, as decreased degradation is seen after DNA damage (Blasius et al.
2014). A component of the microRNA processing machinery, DICER1, was also recently
implicated in APA regulation through regulating RNA degradation (Burger et al. 2016), perhaps
through RNA binding site availability. Thus, the levels of shorter transcripts is kept low except in
cases where resources are diverted elsewhere, such as stress, or when these stable shortened
transcripts possess functional significance.

8

Regulators of Alternative Polyadenylation
Despite the aberrant nature of many prematurely polyadenylated transcripts, there are
undoubtedly a significant number of instances in which stable shortened transcripts generated
by APA are functional. Originally, aberrant transcripts were only detected in studies using
artificial knockdown of exosome complex components. However, APA studies have detected
stable shortened transcripts in basal conditions. The selection during ongoing transcription of
one polyadenylation signal over another goes beyond the DNA sequence-mediated binding
affinity of CPSF to the poly(A) signal, and many factors spanning a range of primary pathways
have been shown to have at least partial responsibility in positive or negative regulation of the
usage of one or more poly(A) sites, as will be discussed.

Splicing Factors
A potent effector of APA studied in the past few years has been the small nuclear RNA
U1 (U1 snRNA). Originally, this non-coding RNA was known for its role as the 5’ splice site
recognition factor. U1 snRNA is the RNA component of the ribonucleoprotein particle U1 snRNP
and is necessary for the downstream steps in RNA splicing (Mount et al. 1983; Krämer et al.
1984). However, work from the Dreyfuss lab has identified a global splicing-independent role of
U1 snRNA in preventing promoter-proximal polyadenylation site usage (Figure 2) (Kaida et al.
2010; Berg et al. 2012). Functioning in a 5’-3’ direction, U1 snRNA used its degenerate RNA
binding capacity to base-pair with a number of cryptic, unused 5’ss, thus masking nearby
cryptic, presumably aberrant poly(A) sites. A decrease in U1 abundance correlates with the use
of the most proximal poly(A) sites. These studies are consistent with earlier work that show that
various components of U1 snRNP can interact with CpA factors (Awasthi and Alwine 2003),
suppressing polyadenylation at the canonical poly(A) site (Boelens et al. 1993; Gunderson et al.
1998; Ashe et al. 2000) and promoting APA (Lou et al. 1998).
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Splicing and CpA are in fact intimately linked, as both events occur within the same
timeframe and transcriptional unit. Interestingly, decreased usage of a particular AAUAAA can
lead to decreased splicing of the most proximal (terminal) intron to the poly(A) signal, but not
upstream introns (Niwa and Berget 1991; Cooke et al. 1999). Decreased usage of a 3’ splice
site also reduced the usage of the adjacent polyadenylation sequence (Niwa and Berget 1991;
Cooke et al. 1999), highlighting the interrelatedness of these processes. Because of this link,
factors affecting one process may be indirectly affecting the other. An example of this
phenomenon is TRAP150, whereby through interaction with both spliceosomal components
(including U1 snRNP) and CpA factors promotes the usage of APA through the utilization of
alternative terminal exons (Lee and Tarn 2014). Similarly, a subunit of the general
transcriptional regulator Mediator; MED23, regulates splicing causing a concomitant activation
of APA through alternative terminal exon usage (Huang et al. 2012)
An intriguing aspect of the competition and/or cooperation of a splice site and an intronic
polyadenylation site is the relative strength of each signaling. The “strength” refers specifically to
the binding affinity of recognition factors to their respective sequences, not only to the 3’ss or
poly(A) signal, but also to surrounding regulatory elements that confer activation or suppression
of the respective site. By and large, a weak polyadenylation signal (any of the variants other
than AAUAAA or AUUAAA) corresponds with a composite terminal exon and no additional
alternative splicing, whereas a strong polyadenylation signal corresponds with an alternative
terminal exon and the occurrence of splicing (Tian et al. 2007). While I have mainly focused on
the effect splicing factors have on CpA, the CpA machinery has also been implicated in splicing
efficacy, such as CPSF (Li et al. 2001). Why might such a coupling occur? Perhaps acting
redundantly as a failsafe to ensure transcription terminates at any particular site and this might
change in different cellular conditions. Thus, this highly interdependent network is controlled by
a variety of factors and sequence elements with a scale of binding affinity to finely tune gene
expression.
10

Cleavage/Polyadenylation Factors
The multitudinous proteins involved in CpA are capable of regulating APA itself in
contrasting fashions to different scales. Given the enormity of the complex(es) (Shi et al. 2009),
I will highlight just a select few examples.
One early example is CstF-64, which is part of the CstF complex. It was found that in
naive B-cells, CstF-64 expression is deliberately repressed, reducing cleavage efficiency of the
immunoglobulin IgM transcript and resulting in usage of a higher affinity, distal poly(A) site
(Takagaki et al. 1996). During differentiation, CstF-64 levels increase, allowing the usage of the
more proximal, lower affinity poly(A) site. This CR-APA event produces a secreted versus
membrane-bound form of IgM (Early et al. 1980).
To characterize the effect of factors known to play roles in CpA on both 3’UTR APA and
CR-APA, depletion of these factors and deep sequencing was performed ( Li et al. 2015).
Through these experiments it was possible to uncouple the regulation of 3’UTR-APA and CRAPA. While subunits of CF I (Figure 1) were found to be the most significant repressors of
proximal APA within the terminal exon, the greatest repressors of CR-APA (i.e. APA in introns)
were U1 snRNA (as mentioned before) and SF3B1; a splicing factor involved in 3’ss definition.
Interestingly, U1 decrease also produces a shorter isoform of the CstF complex subunit CstF-77
(Luo et al. 2013), which in turn can lead to global lengthening of mRNAs, perhaps acting as a
feedback mechanism.
An important and arguably overriding preoccupation with the study of APA is its role in
health and disease. Any incidence of APA dysregulation as an epidemiological factor is
unquestionably evidence of its relevance in cellular homeostasis, and reports are emerging in
this regard. Agami and colleagues discovered that oculopharyngeal muscular dystrophy, a late
onset autosomal degenerative disease, is caused by a triplet repeat expansion in the CpA factor
poly(A) binding protein nuclear 1 (PABPN1) (Jenal et al. 2012). Mutant PABPN1 has a dominant
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negative physical interaction with the wild-type protein, preventing normal inhibition of promoterproximal APA events.
Not only can CpA factors undergo mutations detrimental to the cell but the sequences
they recognize are also subject to similar aberrations. A follow up for a genome wide
association study (GWAS) for systemic lupus erythematosus (SLE) identified a single nucleotide
polymorphism correlating to interferon regulatory factor 5 (IRF5) (Graham et al. 2007). One of
the functional alleles of IRF5 possess a canonical poly(A) signal leading to usage of a
downstream signal, extension of 3’UTR and decrease in mRNA stability.
The ubiquitous nature and general function of CpA machinery offers an explanation as to
why it can affect APA on a global scale. It has also been shown that APA can sufficiently affect
gene expression to drive carcinogenesis or other disease phenotypes (reviewed in Elkon et al.
2013; Tian and Manley 2017).Supporting this idea, overall shortening of 3’UTRs as a result of
APA is capable of driving higher proliferation - a cancer phenotype - by reducing negative
regulatory elements present in the 3’UTR of pro-proliferation mRNAs (Mayr and Bartel 2009).
Mutations in CpA proteins such as PABPN1 and PABPC1 could potentially propagate this effect
as they promote distal poly(A) site usage (Li et al. 2015). In addition, a subunit of CF1 complex,
CFIm25, suppresses proximal poly(A) site usage as a method of tumor suppression in
glioblastomas (Masamha et al. 2014). Thus, the CpA machinery is intimately linked with APA
with ramifications in cancer and other diseases due to the myriad protein factors involved in the
proper regulation of 3’ end processing.

Other Factors and Conditions
The regulation of APA is not restricted to factors involved in splicing and CpA. Gene
expression is tightly controlled to allow temporal and spatial dynamic changes and this involves
a number of protein components from diverse pathways, and APA is no exception. Indeed, a
staggering number of conditions are capable of shifting CpA from one site to another.
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A significant portion of proteins within the nucleus are transcription factors (TFs).
Loosely put, a transcription factor is any chromatin-associating protein that can positively or
negatively influence mRNA expression (Latchman 1997). This umbrella definition makes TFs
prime candidates for roles in APA, for they are capable of being present at ground zero of the
reaction, influencing either the reaction itself or the factors enacting it. One such candidate,
polymerase associated factor 1 (PAF1), was originally characterized as an RNAP II interactor
necessary for positive regulation of certain genes (Shi et al. 1997). By downregulating PAF1
complex subunits expression, later research uncovered a role in suppressing not only proximal
3’UTR-APA but also CR-APA in mammalian cells (Yang et al. 2016).
Not only transcription factors, but the transcription process itself can influence the
selection of poly(A) signals. For instance, high transcriptional activity measured by RNA-seq
data (RNA abundance) indicated that increased output generated shorter 3’UTR isoforms,
whereas longer isoforms were more likely to occur in instances of low transcription activity (Ji et
al. 2011). However, it was not clear whether the link between transcription activity and APA was
due to increased transcription initiation or elongation rate. While a Drosophila mutant model with
lowered elongation favors proximal poly(A) signal choice (Pinto et al. 2011), RNAP II Serine 2
phosphorylation in mammals, a marker for elongation, does not correlate with APA in some
conditions (Fusby et al. 2016).
Part of the reason that APA has become such a highly invested topic is its usage in
response to stimuli and its role in certain cellular events, notably during development and
differentiation (Ji et al. 2009; Hilgers et al. 2011). For example, synaptic activity and calcium
influx into neurons cause changes in gene expression, but a remarkable effect is that genes
under the influence of the transcription factor MEF2 would in many cases undergo CR-APA,
producing truncated transcripts of potentially different functions (Flavell et al. 2008). Although
the underlying mechanism is unclear, post-synaptic calcium influx is required.
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APA can result not only because of preordained, programmed events such as
development. As occasion demands, unplanned and stochastic events require a robust and
coordinated response to ensure cellular and/or organismal survival. A pertinent example of this
type of cellular response would be genotoxic stress, such as UV or deoxyribonucleotide
depletion. Recent studies have indicated widespread APA as a result of the UV-induced DNA
damage response (DDR) (Devany et al. 2016; Hollerer et al. 2016). Thus, APA is a highly
orchestrated and global regulator of gene expression for a variety of conditions controlled by
numerous factors from multiple pathways for myriad purposes, including DDR.

DNA Damage Response
DDR is a concerted effort undertaken to ensure the survival of either the cell or the
organism following stress. Cellular stress can come as either genotoxic; affecting the genome;
mutagenic, or non-genotoxic; affecting factors and/or processes not directly in contact with
DNA. The appropriate response is dependent on both the intensity and duration of each specific
insult the cell endures. As such, several resource-dependent mechanisms are in place for
robust DNA repair and recovery of homeostasis (cell cycle arrest) in instances where damage is
tolerable, or efficient cellular suicide (apoptosis) when the lesional load is too great to risk
carcinogenesis or other sickness to the organism. To highlight the range of mechanisms
required to deal with specific damage, several examples of stressors and responses are
indicated in Figure 3.
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Figure 3: Schematic of the basic principles behind DDR. Labels at the top
indicate various genotoxic insults. Labels at the bottom represent responsive
pathways, which are not mutually exclusive to any one particular stress or to
each other.

Despite the heterogeneity of DDR, a major effector for the vast majority of responses is
the transcriptional activator p53 (Kastan et al. 1991; Farmer et al. 1992). The p53-centric
response to DNA damage is outlined in Figure 4. As a result, stress-specific outcomes have
evolved such as differential DNA binding cooperativity for the p53 tetramer (Schlereth et al.
2010), and pulsed vs sustained expression of p53 protein levels (Purvis et al. 2012), each mode
inducing gene expression in characteristic ways to enact either cell cycle arrest or apoptosis.
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Figure 4: Diagram of initial sensors and effectors after DNA damage.
ATR and ATM kinases induct downstream phosphorylation cascades,
including of CHK1, CHK2, and p53, allowing for DDR. Adapted from
Moorhead, 2007.

In order to induce these effects, multiple pathways are regulated at the levels of
translation, transcription, and everything in between. For example, at the post-transcriptional
level, the cleavage factor subunit CstF-50 and tumor suppressors BRCA1/BARD1 interact after
UV-mediated DNA damage and this interaction inhibits nascent RNA transcript cleavage
(Kleiman and Manley 1999, 2001), reducing overall mRNA levels. Later research identified that
also under the CstF-50/BRCA1/BARD1 functional interaction is the polyubiquitination and
degradation of RNAP II (Kleiman et al. 2005), and that CstF-50 was necessary for maintaining
cell viability after UV and for efficient transcription-coupled DNA repair (Mirkin et al. 2008).
Interestingly, it was found that p53 enhanced mRNA 3’ end processing inhibition in a
transactivation-independent role (Nazeer et al. 2011). Thus, mRNA processing and DDR are
intimately linked.
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An intriguing example of stress-specific DDR pathways is that of the tumor suppressor
p21, encoded by CDKN1A gene (Xiong et al. 1991; Harper et al. 1993). An intrinsically
disordered protein, p21 has two functional domains at its N- and C-terminal ends (Chen et al.
1995). The N-terminal is a global inhibitor of cyclin-dependent kinases (CDK binding domain),
preventing cell cycle progression; the C-terminal is an inhibitor of DNA polymerase processivity
factor PCNA (PCNA-binding domain), preventing DNA synthesis. The established consensus is
that upon stress, upregulation of p53 leads to transcriptional activation of CDKN1A gene via
designated p53 binding sites (Laptenko et al. 2011), increasing p21 mRNA and, consequently,
protein levels for enacting cell cycle arrest. Transcriptional activation of p21 independently of
p53 has also been reported (Huang et al. 2000; Takano et al. 2001). While CDKN1A/p21
regulation by p53 is well documented, the regulatory mechanism involved depending on the
type of stress is less understood.

Stress-specific regulation of CDKN1A gene and p21 expression
Gottifredi and colleagues first noted a stress-specific difference in p21 regulation
(Gottifredi et al. 2001). They described that while CDKN1A mRNA and protein are induced
strongly after γ-radiation treatment by activated phosphorylated p53, both p21 mRNA and
protein fail to accumulate after hydroxyurea (HU) treatment despite high levels of activated p53.
HU inhibits the conversion of rNTPs to dNTPs disrupting DNA synthesis and causing G1/S
blockage as part of S-phase stress (Yarbro 1992). Further studies in stress-induction of p21
discrepancy showed that p53 is acetylated at residue 382 in γ-radiation but not hypoxia
(Koumenis et al. 2001) and that this p53 posttranslational modification is necessary for strong
CDKN1A mRNA induction. Besides differences in the CDKN1A promoter activity were found,
specifically in the recruitment of general transcription factor (GTF) (Espinosa et al. 2003). For
example, TFIIB recruitment increases only after the topoisomerase inhibitor doxorubicin
treatment, whereas TAF1 (part of the TFIID complex) increases only after UV damage.
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However, in this study the treatments were for different durations, so the observed alternative
GTF recruitment could have been due to the timing after damage rather than the type of stress
itself. ChIP data showed that after UV treatment p53 recruitment increases at CDKN1A
promoter at a greater fold change rate than the induction of CDKN1A mRNA (Magrini et al.
2007). After UV treatment, TAF1 is recruited alongside p53 prior to other GTFs (Li et al. 2007).
Differences in H4 acetylation, specifically at the TATA box of CDKN1A gene, were also noted
between γ-radiation (acetylated H4) and UV treatment (not acetylated H4) (Hill et al. 2008).
Interestingly, increased levels of p53 after treatment with Nutlin-3, which inhibits the interaction
of p53 and its suppressor MDM2 (Shangary and Wang 2009), strongly induces CDKN1A mRNA
levels and the recruitment of specific components of the GTF Mediator complex in the absence
of DNA damage (Donner et al. 2007). Together, these studies suggest that strong induction of
CDKN1A mRNA might be a default mechanism during DDR but the recruitment and/or loss of
recruitment of factor(s) under UV or HU treatment might delay CDKN1A mRNA induction.
Delving deeper into what the signal(s) might be pertaining to weaker CDKN1A mRNA
upregulation despite comparable levels of p53 and RNAP II at the promoter after DNA damage,
several studies have converged on inhibition of transcription elongation (Mattia et al. 2007; Valin
and Gill 2013; Kumari et al. 2013). Different from the phenomenon of abortive initiation; a
transcriptional elongation regulation process produces shorter truncated transcripts (8-10 nt)
prior to productive elongation of full-length transcripts (Munson and Reznikoff 1981; Adelman
and Lis 2012). As part of this process, DDR kinases Chk1 (Beckerman et al. 2009) and p38
(Kumari et al. 2013) were found to inhibit and activate, respectively, transcription elongation of
CDKN1A gene under damaging conditions. Ctk1 is another example of a kinase involved in
mRNA elongation induction and this is achieved by serine-2 phosphorylation of RNAP II CTD, a
marker for active elongation and promoter of 3’ end processing (Ahn et al. 2004). ChIP
experiments also showed increased levels of the cleavage factor subunit CstF-64 at the 3’ end
of CDKN1A gene upon Chk1 inhibition, supporting the idea that Chk1 depletion allows strong
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CDKN1A mRNA induction (Beckerman et al. 2009). Surprisingly, the inhibition of CDKN1Aspecific splicing regulator, which bound strongly to intron 1, increases the levels of “intronic
sequences downstream of the promoter (Chen et al. 2011). Hence, a number of factors are at
play at CDKN1A gene regulating mRNA elongation co-transcriptionally and resulting in shorter
truncated transcripts.

Long Non-Coding RNA
Although the central dogma dictates that DNA makes RNA to act as the intermediate
messenger for protein production (Crick 1970), it was soon clear that it is not quite so simple. To
begin with, the discovery of rRNAs in a ribonucleoprotein complex as well as tRNAs necessary
for translation (Hoagland et al. 1958) meant that RNA could be used for structural and/or
catalytic roles. This is consistent with the idea of the “RNA world” (Gilbert 1986), which
proposes that the most primitive cells operated with RNA as the primary method of inheritance
and function.
A non-coding RNA can be broadly categorized as any product of transcription regulated
by cell type or developmental stage, therefore not a result of euchromatic pervasive
transcription, that is not expected to code for a protein by computational or experimental
analysis but has function. For the purposes of this thesis, non-coding RNAs can again be split
into small non-coding RNAs (sncRNAs; <200 nt after processing) and long non-coding RNAs
(lncRNAs; >200 nt). Some examples of small non-coding RNAs include snRNAs involved in
splicing, snoRNAs that target rRNA modifications, miRNAs that target mRNAs for stability and
translation regulation, and piRNAs that act similarly to miRNAs but are involved in posttranscriptional gene silencing of transposons (reviewed in Eddy 2001; Siomi et al. 2011). Many
of these RNAs work in conjunction with proteins and undergo post-transcriptional processing for
maturation.
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The lncRNA class is a much newer and arguably more heterogeneous group of noncoding RNAs. The discovery of sncRNAs, which function almost invariably by base pairing to
other RNA targets, has been simpler by searching for sequence homology and transcriptional
correlations. On the other hand, while some lncRNAs also undergo base pairing in trans, for a
number of discovered lncRNAs their function resides in their secondary structure or binding to
proteins containing RNA recognition motifs (RRMs) (Ponting et al. 2009). LncRNAs can be
generated intergenically and intragenically (from within a protein-coding gene); both sense and
antisense, encased entirely within an intron, emanating from the same promoter or be
bidirectional from the promoter (Katayama et al. 2005).

Figure 5: Schematic of how lncRNAs could interact with other components and
affect cellular processes. Proteins are in grey blobs, lncRNAs in purple, mRNAs
in pink. Adapted from Scheuermann and Boyer 2013.

One of the earliest lncRNA to be defined and the poster child of a functional lncRNA was
the X-inactive specific transcript (XIST) (Brown et al. 1991). This 17 kb transcript possesses no
open reading frame, is transcribed for the X-chromosome that will be silenced during Xchromosome inactivation, and serves to coat its host chromosome facilitating inactivation
(Brockdorff et al. 1992; Ng et al. 2007). In the subsequent years, a number of other lncRNAs
were found with varying functions, several of them working to regulate transcription in cis
(Shamovsky and Nudler 2006). Since the turn of the decade, the number of annotated lncRNA
transcripts approached an estimated 20,000 mRNA-producing genes (Volders et al. 2013), and
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the number continues to increase with lncRNAs involved in a wide range of cellular pathways,
such as DNA damage.

LncRNAs in the DNA damage response
A seminal manuscript investigating lncRNAs in DDR identified a plethora of transcripts
originated around cell cycle regulated promoters in human cells (Hung et al. 2011). Other study
also identified functional multi-exonic lncRNAs regulated by various transcription factors in
mouse cell culture (Guttman et al. 2009). Understandably, lncRNAs transcribed in the vicinity of
genes undergoing regulation under stress are also regulated themselves under damaging
conditions. In addition, not all lncRNAs produced are gene-specific. LncRNAs can be
synthesized as the result of and at the sites of DNA damage, mediating the recruitment of other
RNAs and damage sensor protein factors for progression of DDR (Michelini et al. 2017).
Of the numerous lncRNAs described, a surprisingly high amount exist in and around
CDKN1A (Figure 6). The first discovered was lincRNA-p21 and, as such, it has been subject to
a plethora of research studies (Yoon et al. 2012; Dimitrova et al. 2014; Hall et al. 2015) as well
as a recent review of its role in cancer (Chen et al. 2017). As the name indicates, it is a long
intergenic non-coding RNA on the same chromosome arm as CDKN1A. Curiously, studies
using siRNA against lincRNA-p21 identified a role in suppressing CDKN1A mRNA translation
through base pairing (Yoon et al. 2012), whereas a genetic knockout of lincRNA-p21 showed a
in cis role in activating transcription of CDKN1A (Dimitrova et al. 2014). Interestingly, absolute
quantification experiments indicated that lincRNA-p21 level is ~2 copies per cell at basal
conditions, and ~8 copies per cell after DNA damage, highlighting the impact low abundance
transcripts can have.
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Figure 6: Non-coding RNAs generated around CDKN1A. Each elliptical, other
than eRNA, represents a protein regulating or being regulated by a lncRNA.
eRNA represents an enhancer RNA generated from within intron 1 proximal to
exon 2. Green lines generate transcription start sites (TSS) for each lncRNAs
except for CDKN1A TSS, which produces full-length CDKN1A. Image adapted
from Subramanian et al. 2013.

In their manuscript, Hung and colleagues (2011) described a lncRNAs originated around
CDKN1A promoter using large scale sequencing: an antisense transcript that they named p21
associated lncRNA DNA damage activated (PANDA). As with other lncRNAs in the region,
PANDA levels are regulated in a p53-dependent manner and, thus, are damage induced. Its
role was initially thought to be in suppressing apoptosis through interaction with transcription
factors. PANDA function has since been expanded to interact with another factor, SAFA,
affecting the recruitment of chromatin modification enzymes to repress senescence-activating
genes in proliferating cells. Thus, CDKN1A-associated lncRNAs can have cell-stage and cellfate specific functions (Flynn and Chang 2014; Lee et al. 2017).
A common theme of all these lncRNAs is their dependence on p53. Importantly, some
lncRNAs can also regulate p53 expression. For example, damage induced noncoding (DINO)
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lncRNA, a non-coding RNA, has been shown to be partly responsible for the p53 response
(Schmitt et al. 2016). DINO binds to p53 protein and it stabilizes it, and knockdown of DINO
levels blunted the p53 response after DNA damage. DINO expression can activate damage
signaling and cell cycle arrest in the absence of DNA damage. Thus, damage induced lncRNAs
can not only be functional in DDR, but work in feedback loops to help orchestrate the entire
response.
Most of the lncRNAs induced during DDR have the general trend to induce rather
suppress expression and do not show functional overlapping during the response showing
individual functions. Additionally, an enhancer region has been identified around the CDKN1A,
which produces an enhancer RNA (Léveillé et al. 2015). Enhancer regions are DNA elements
that serve to activate or “enhance” transcription of genes, many times located at sites
particularly distal to gene to be activated (Cleutjens et al. 1997). Several mechanisms have
been proposed for such occurrence but usually it is thought that DNA looping is involved
bringing the enhancer region and gene promoter into proximity (Wang et al. 2005; Lupiáñez et
al. 2015). More recently, RNAP II-driven transcription of these enhancer regions has been
observed and the short non-polyadenylated RNAs generated have been shown to have
functions in enhancing gene expression (Kim et al. 2015).
As CDKN1A possesses a long first intron, the probability to find regulatory sequences
might be high. A genome-wide investigation into p53-regulated enhancers identified a binding
site for p53 within CDKN1A first intron, closer to exon 2 than exon 1, shown as enhancer RNA
(eRNA) in Figure 6 (Léveillé et al. 2015). This eRNA is fundamental in p53-dependent regulation
of CDKN1A gene expression and, interestingly, a lncRNA generate elsewhere in the genome is
involved in the regulation of the eRNA. Thus, a number of non-coding RNAs are intricately tied
with expression of a highly documented gene, CDKN1A.
In this thesis, I propose to characterize a lncRNA produced from CDKN1A after DNA
damage due to APA. My studies indicate that it is similar in some aspects to the other CDKN1A23

associated lncRNAs, such as its expression being dependent on p53. However, this lncRNA
differs from the others in that it is sense-strand and intragenic to CDKN1A, utilizing the same
transcription start site than the full-length CDKN1A transcript. I have identified some of the cell
types and conditions in which this CDKN1A APA transcript is expressed. I have performed
experiments to identify that this transcript is non-coding as well as spliced. My studies show the
localization of this CDKN1A APA isoform. I also present evidence that APA isoform is regulated
by RNA-binding protein HuR through direct RNA-protein interaction. Further, I show that
depletion of APA under non-stress conditions is capable of downregulating p21 protein without a
corresponding effect on mRNA abundance, leading to increased cell proliferation.
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CHAPTER II

INTERPLAY BETWEEN PARN-MEDIATED DEADENYLATION AND miRNA REGULATION
IN THE DNA DAMAGE RESPONSE
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Background

Polyadenylation is a post-transcriptional modification of mRNA responsible in part for
regulating the life-cycle of the modified RNA (reviewed in Colgan and Manley 1997). The length
of a poly(A) tail is a highly regulated organism specific event. The processive addition of
adenosines can be stimulated by various CpA factors, such as CPSF (Wahle 1995). Poly(A) tail
length (~200-250 adenosines in humans) is controlled by PABPN1 that is required to allow the
stimulatory dynamic interaction of PAP to CPSF bound-AAUAAA sequence, once the poly(A)
tail reach ~200 bp is then restricted allowing for tail elongation termination to take place (Kühn
et al. 2009). The poly(A) tail protects the mRNA molecule from enzymatic degradation in the
cytoplasm (Fuke and Ohno 2008) and aids in export of the mRNA from the nucleus, and
translation . Due to the relevance of this post-transcriptional action in controlling gene
expression, poly(A) tail length can also be controlled through the reverse, that is, deliberate
removal of adenosines from a set length of poly(A) at the 3’ end of the mRNA, known as
deadenylation. This mechanism is relevant because its functional consequences in controlling
mRNA stability and, more recently described, translation efficiency, both of which can be altered
due to changes in poly(A) tail length in both cytoplasm and nucleus (Weill et al. 2012).
Deadenylation can be used as a method of fine-tuning rather than as a demolition agent leading
to mRNA decay by 3’-5’ exonucleases. In fact, deadenylation can be used as a quick-fire way of
adapting to changing cellular conditions in a time-frame not accomplishable by transcriptional
regulation (Shyu et al. 1991). In eukaryotes, there are two distinct families of deadenylases
categorized by their difference in the amino acid residues used to coordinate their respective
Mg2+ (reviewed by Goldstrohm and Wickens 2008).
For the purposes of this thesis, I will focus on poly(A) specific ribonuclease (PARN)
deadenylase. PARN is a trimeric complex that exists as both a 74 kDa and a 54 kDa protein,
and its enzymatic activity is stimulated by binding to the mRNA 5’ cap (Martın
́ ez et al. 2000).
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PARN was identified separately in both cytoplasm (54 kDa, Körner and Wahle 1997) and
nucleus (74 kDa, Aström et al. 1991) in mammalian cells. Work from our lab also demonstrated
that PARN is involved in DDR, as the CstF-50/BRCA1/BARD1 complex activated PARN activity
by preventing PARN interacting with its inhibitory component cap binding protein 80 (CBP80;
Cevher et al. 2010). In addition, PARN is involved in a feedback loop with p53, whereby TP53
mRNA levels are kept low by a basal activity of PARN under non-stress conditions and p53
protein activates PARN to downregulate mRNAs as part of a general response under stress
conditions (Devany et al. 2013; Newman et al. 2017). Interestingly, DDR genes, including TP53
transcript, are not affected by this PARN-mediated regulation during DDR. The factors involved
in PARN-mediated recruitment to TP53 mRNA were unknown.
mRNA deadenylation is controlled by cis-acting regulatory elements, which include RBP
binding sites and miRNA targeting sites, within the 3' UTRs of mRNAs. For example, in
Drosophila, RBP Nanos recruits NOT4 deadenylase to regulate mRNA translation (Kadyrova et
al. 2007). Additionally, microRNA-mediated recruitment of deadenylase to transcripts has been
observed in mammalian systems (Wakiyama et al. 2007), and has been seen to be a general
cytoplasmic pathway (Wu et al. 2006). The nuclear component of this mechanism has not been
extensively studied. While several RBPs are involved in the recruitment of PARN deadenylase
to its target mRNAs, the role of miRNA in PARN recruitment to the mRNA has not been
elucidated.

Results

It was previously demonstrated that PARN binds to TP53 mRNA in a region that
includes AU-rich elements (AREs) present in the 3’UTR, downregulating mRNA expression
under non-stress conditions (Devany et al. 2013). Directly adjacent to the ARE are overlapping
miRNA sites for miR-125b (Le et al. 2009) and miR-504 (Hu et al. 2010) (Figure 7A), which are
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both known to negatively regulate TP53 mRNAs. While earlier research showed that
deadenylation is interlinked with the miRNA pathway (Wu et al. 2006) and that the cytoplasmic
deadenylase CAF1-CCR4-NOT complex is involved in the pathway (Eulalio et al. 2009), the role
of PARN deadenylase in miRNA-dependent mRNA degradation has not been elucidated.
Therefore, we were interested to test whether there was interplay between the nuclear
deadenylase PARN and miRNA pathway in mammalian cells (Zhang et al. 2015).
My contribution to this published manuscript (Zhang et al. 2015) was to elucidate
whether the presence of the miRNA targeting sites and/or the ARE sites were necessary for the
binding of PARN or the catalytic component of the miRNA machinery, Argonaute 2 (Ago2), to
the TP53 mRNA. To accomplish this I performed RNA pull-down assays using in vitro
transcribed biotinylated RNA encompassing different derivatives of TP53 3′ UTR, nuclear
extracts (NEs) from HCT116 cells. After NEs were incubated with biotinylated RNAs, I
immunoassayed the pull-down against Ago-2 and PARN to check for binding relative to the
input sample (Figure 7C). I constructed expression vectors for in vitro transcription of p53 3’UTR
with derivatives including the complete sequence (WT TP53), deleted ARE (noARE), deleted
125b/504 miR sites (nomiR), or both (noBOTH) (Figure 7B). My results indicate that a
biotinylated RNA encompassing WT TP53 3’UTR pulled-down PARN and Ago-2 from NEs
(Figure 7C). I observed that a negative control for pull-down, topoisomerase II, was detected
only in the input. When RNA pull-down assays were performed with RNAs encompassing
mutant variants of TP53 3′UTRs, my results indicated the RNA–PARN interaction depended on
the presence of both the ARE sequence and the adjacent miR-504/miR-125b targeting site
(Figure 7C). As expected, Ago-2/RNA interaction was not affected by the replacement of the
ARE. As the RNAs did not include other miRNA targeting sites present in the TP53 3’UTR, such
as miR-25 and miR-30d targeting sequences, the binding of Ago-2 to those miRNA targeting
sites was not detected in these assays. While the loss of the miR-504/miR-125b targeting site
decreased Ago-2/RNA binding, the loss of the ARE in the noBOTH derivative further reduces
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Ago-2 binding. As described by others (Jing et al. 2005), this supports the idea that the
association of an ARE-BP may affect Ago-2 biding to TP53 3′UTR. Some PARN was pulleddown by the noBOTH construct, probably due to the presence of the most distal ARE of TP53
3′UTR in the biotinylated RNAs.

Discussion

This manuscript was the first to show nuclear deadenylase PARN’s role in miRNAdependent mRNA regulation in mammalian cells. The study uncovers a specialized feedback
loop, whereby under non-stress conditions PARN binds to p53 mRNA in conjunction with the
miRISC complex to downregulate p53 expression to allow for cellular proliferation (Zhang et al.
2015). My data included in the manuscript indicate that both the ARE and the miRNA targeting
sites contribute to Ago-2 binding, as observed by the additive effect of removing both sites
compared to only one. However, the largest reduction in PARN binding is by the removal of the
miRNA targeting site, since the removal of both sites has a similar effect to the removal of only
miRNA targeting site. These results suggest that the miRNA targeting site and, hence, the
recruitment of miRNA-induced silencing complex (miRISC) might be the primary factor
underlying PARN recruitment to TP53 mRNA. Unlike Ago-2, which is mostly dependent on
miRNA binding for recruitment to its target RNA (Atwood et al. 2016), PARN is capable of
binding to both the 5’ cap structure as well as the poly(A) through its RNA recognition motif
(RRM).
Under UV conditions, p53 protein is upregulated via phosphorylation, preventing its
interaction with its cognate ubiquitin ligase MDM2 (Inoue et al. 2001). The upregulated p53
protein then binds to and activates PARN, facilitating deadenylation of a larger number of
targets, including housekeeping genes (Devany et al. 2013). Other studies have shown that
under UV conditions 3’UTR of TP53 mRNA is protected by an intramolecular secondary
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structure known as a quadruplex (Decorsière et al. 2011; Newman et al. 2017), potentially
preventing accessibility by the deadenylation and miRNA machinery. Consistent with the Gquadruplex studies, the research
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Figure 7: Binding of the miRNA and deadenylation machinery to TP53 mRNA
depends on ARE sequences and miRNA targeting sites. (A) Sequence of TP53 mRNA
3′UTR. miRNA targeting sites and AREs are shown. miR-125b/miR-504 binding sites
(red) are adjacent to an ARE (blue). (B) Diagram of constructs with different 3′UTR
sequences from the TP53 gene. The sites of replacement are indicated: miR125b/miR-504 binding site (red), ARE (blue). (C) Both ARE and adjacent miR-125b
targeting signal at TP53 3′UTR are necessary for PARN binding. RNA pull-down
assays were performed using biotinylated RNA carrying WT or signal replaced TP53
3′UTR (noARE, nomiR and noBOTH) and NEs from HCT116 cells. A representative
pull-down reaction from three independent assays is shown. Ten percent of the NE
used in the pull-down reactions is shown as input. The means ± standard deviation of
PARN and Ago-2 signals are indicated. Modified from Zhang et al. 2015.
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from our lab showed that TP53 mRNA is also protected from degradation by downregulation of
miR125b under damaging conditions (Zeng et al. 2012; Zhang et al. 2015).
This is consistent with my data (Figure 7) as the loss of miRNA binding capability results
in reduced PARN binding and, thus, deadenylation and instability of the mRNA. Additionally,
certain miRNAs involved in TP53 mRNA regulation were detected to bind PARN by
immunoprecipitation experiments, and this binding was reduced after UV treatment (Zhang et al.
2015). Interestingly, the reduced miRISC/PARN binding may not only be due to the lowered
interaction at mRNA 3’UTR but also due to PARN role in miRNA maturation (Yoda et al. 2013).
PARN has been shown to mediate trimming of the 3’ ends of miRNA precursors promoting their
maturation. While trimming of pre-miRNAs is not essential for silencing of target mRNAs, it is
possible that this maturation mechanism might affect the levels of mature miRNA.
Recent computational work has highlighted ARE sequences “hotspots” exhibiting
enhanced binding of numerous RBPs and other cellular components that interact with mRNA,
such as miRNAs (Plass et al. 2017). Likewise, RBPs were found to be enriched at miRNA
binding sites. Such overlapping between AREs and miRNA binding sites appears to be a
general phenomenon and supports our observations with the TP53 mRNA. In many cases,
RBPS and miRISC functions are opposite. Data presented in this manuscript indicate that HuR,
a RBP that stabilizes TP53 mRNA and binds TP53 ARE (Mazan-Mamczarz et al. 2003), can
revert the recruitment of PARN to TP53 mRNA by miR-125b-loaded miRISC (Zhang et al.
2015). Genome wide studies also showed that HuR binding sites also overlap considerably with
miRNA targeting sites (Mukherjee et al. 2011).
What might the relevance of this PARN-p53 axiom be as a feedback loop? One can
imagine that while miRNA levels are reduced and mRNA secondary structures are acting as
steric hindrances to PARN recruitment, the p53-dependent activation of PARN could eventually
reach a threshold whereby even the most minimal binding to RNA (Figure 7C, noBoth) could
permit deadenylation and instability of TP53 mRNA, thus lowering p53 levels and reducing
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activation of PARN under non-stress conditions. Interestingly, PARN mutations have been
detected in patients with developmental delay and mental retardation (Dhanraj et al. 2015), and
dysregulated apoptosis, possibly through elevated p53 levels, is a hallmark of developmental
delay phenotype (Chester et al. 1998). In the future, it will be interesting to determine whether
the phenotypes seen in patients with PARN mutations have relevance to its regulation of p53
under non-stress conditions.
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CHAPTER III

BIOCHEMICAL VALIDATION OF BIOINFORMATIC ANALYSES INVESTIGATING
ALTERNATIVE POLYADENYLATION DURING THE DNA DAMAGE RESPONSE IN
MAMMALIAN CELLS
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Background

Alternative polyadenylation (APA) has been shown to be a widespread phenomenon
across multiple model organisms, such as fish (Ulitsky et al. 2012), plants (Wu et al. 2016),
yeast (Ozsolak et al. 2010), fly (Smibert et al. 2012), and mammals (Xiao et al. 2016). Given the
enormity of nucleotide abundance in any given genome, with approximately 3 billion bases in a
human cell, up until the turn of the century the extent and impact of APA was unknown and
intangible. However, following the advent of the human genome project (HGP; Venter et al.
2001), contextual knowledge of non-repetitive sequences in our genome in conjunction with an
expanding annotation of what defines a gene by the Encyclopedia of DNA Elements (ENCODE)
project (ENCODE Project Consortium et al. 2007) has allowed for systematic elucidation of
canonical and non-canonical APA sites.
Since the human genome project was published, the cost of sequencing has mercifully
decreased. The HGP was completed using Sanger sequencing (Sanger, Nicklen, and Coulson
1977), a now antiquated but faithful method. Following great efforts to find strategies to
decrease the cost of sequencing DNA (Schloss 2008), a number of companies developed highthroughput sequencing (HTS) techniques such as the Roche 454 pyrosequencer and
Solexa/Illumina sequence analyzer (Reuter et al. 2015). Both of these types, while offering
different throughput capabilities and individual read lengths, operated on the same basic
principle. The DNA or RNA to be sequenced is fragmented to ~1kb segments, ligated to an
adaptor annealed to beads on a slide. The sample is then incubated with a single type of
deoxynucleotide (dNTP). If the first nucleotide in the sequence corresponds to the type of dNTP
added, a light reaction will occur due to polymerase-mediated incorporation. The dNTP type is
then washed away and replaced with the “next” dNTP. If no light reaction occurs then the next
letter in the sequence does not correspond to the dNTP added, and nucleotides are washed
and added until the light reaction does occur. This process is repeated simultaneously across
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thousands of wells up until each fragment is fully sequenced. This, combined with exponentially
increasing computing power, allows for many samples and conditions to be analyzed in parallel
and the high readthrough confirms the results obtained.
The detection of APA in myriad model organisms (Ulitsky et al. 2012, Wu et al. 2016,
Ozsolak et al. 2010, Smibert et al. 2012, Xiao et al. 2016) has inspired experimental methods
designed specifically to detect the site of CpA during transcription (Chen et al. 2017). A number
of methods have been developed to enrich for information of the 3’ end of the transcriptome,
which can be broken down into two main categories, each with their own advantages and
disadvantages. For example, samples can be primed from oligo(dT), such as in PAS-seq
(Mangone et al. 2010), which is easy to implement but suffers from priming from internal
oligoadenine stretches, leading to false positive results for CpA. Alternatively, samples can
undergo RNA manipulation, such as with 3’ Region Extraction and Deep Sequencing
(3’READS; Hoque et al. 2012) (Figure 8). In 3’READS, RNA is fragmented followed by basepairing to a 45 nucleotide thymine stretch, which enriches for long canonical poly(A) tails, as
opposed to oligo(A) tails added by polymerases other than PAP (reviewed in (Schmidt and
Norbury 2010). The enriched RNA is then freed by RNase H digestion and undergoes deep
sequencing, alleviating the requirement for oligo(dT) priming and thus circumventing the issue
of internal priming. The disadvantages are that this process is laborious and time consuming
due to the extensive RNA manipulation required (Chen et al. 2017). As of 2016, a refined
version, known as 3’READS+, was developed that requires lower starting quantity of RNA and
allows the analysis of RNA fragments with an optimal number of terminal adenines, increasing
data quality and detection of genuine polyadenylation sites (Zheng et al. 2016).
Our studies were aimed to explore the mechanisms and consequences of APA on UVinduced DNA damage (Devany et al. 2016). Overall, we found that APA was induced after UV
treatment, and that this is dependent on decrease in U1 snRNAs levels, as artificially
manipulating U1 levels altered APA occurrence. We found that 3’UTR APA did not correlate
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with lengthening or shortening globally, as examples of both were found with no bias one way or
the other. As 3’READS+ was developed after the publication of the manuscript, we utilized
3’READS in collaboration with Dr. Tian (Rutgers University). As discussed later in this Chapter,
it is possible the data we uncovered may be lacking the detection of genuine CpA events that
occur immediately downstream of A-rich sequences. Interestingly, we also found that intronAPA underwent 2-fold increase, with promoter-proximal APA in genes with a long first intron
highly represented. Our study described a significant gene regulatory scheme in DDR where U1
snRNA controls gene expression via the U1-APA axis.

Figure 8: Schematic protocol for 3’READS. Following extraction, RNA is
fragmented prior to binding to custom T-rich oligo ligated to beads. Bound
fragments are RNase H treated to digest portion of poly(A) tail. After ligation of
known adaptor sequences, remaining RNA undergoes amplification and
sequencing, before aligning to genome. Adapted from (Hoque et al. 2014).
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Results

APA has been previously described to occur in damaging conditions from yeast to
mammals (Graber et al. 2013; Dutertre et al. 2014). The most comprehensive characterization
of APA has been in 3’UTR (Tian and Manley 2017). Splicing component U1 snRNA is a dosedependent global regulator of APA in both mouse and human (Kaida et al. 2010; Berg et al.
2012). Previous studies showed that levels of U1 snRNA decrease dramatically after UV
damage (Eliceiri and Smith 1983; Morra et al. 1986). Levels of canonical mRNA also undergo
downregulation after UV treatment (Cevher and Kleiman 2010). Thus, we were interested
whether UV treatment has an effect on APA as an induced mechanism of gene expression
control. We performed 3’READS on samples from UV treated colorectal carcinoma epithelium
RKO cells (Brattain et al. 1981; Marks et al. 1983).
My contribution to this project was to both confirm the genome-wide analysis of APA
occurrence under DDR conditions in a number of genes, and to further confirm the role of U1
snRNA in this response. Gene Ontology (GO) analysis of genes undergoing APA indicated
that different biological processes were affected by 3ʹUTR-APA and intronic APA. To validate
the genome-wide analysis, I examined 3ʹUTR- and intron-APAs for genes indicated in Table
1. I selected genes that encompassed a number of different biological pathways and
mechanistic functions, as well as having bias for genes with a high reads per million (RPM)
during sequencing to aid their detection.
To validate the genes selected from our genome-wide analysis, I examined 3ʹUTR- and
intron-APAs following the strategies shown in Figure 9A. Briefly, nuclear RNA was isolated from
colon carcinoma HCT116 cells after recovery from UV treatment, then complementary DNA
(cDNA) was synthesized using reverse transcription with oligo(dT) primers followed by
quantitative reverse transcription–PCR (qRT–PCR) was performed. Specific primers were used
to detect intron-APA products (short isoform) and full-length mRNAs (long isoform). A similar
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strategy was used to detect 3ʹUTR-APA products. To allow the comparison of the amplified
products, the primers were designed to keep the amplicons of similar lengths for both intronic
and full-length sequences. The results are indicated in Figure 9B-C. The data analysis indicate
that differential poly(A) site usage can be detected on an individual gene basis, and that both
isoforms were sufficiently abundant to be measured via qPCR. The data also indicate that these
events are indeed occurring and are not the result of false positives due to (dT) priming to
internal adenosines. Major changes in the distal/proximal ratio for teach individual gene were
not detected in the analysis of UV-induced 3ʹUTR-APA in the 0–0.5 h window (Figure 9B).
However, changes in the usage of poly(A) signal for individual genes were detected after UV
treatment in the 0–2 h window, favoring either distal or proximal poly(A) signal. It is possible that
the 3’READS analysis might represent the overall behavior of the total genes analyzed,
indicating that there was no global direction of 3ʹUTR length changes under these conditions.
Using the same strategy, I observed that intronic-APA was being activated, usually at
the 2 h recovery time point following UV damage. Interestingly, the intronic-APA/full-length
canonical mRNA ratio showed that in some instances the levels of intronic transcript constituted
>30% of the transcriptional outcome, as was the case with POLR2A and EFNB2. Importantly,
CDKN1A and POLR2A were at the hub of the networks significantly associated with intronic
poly(A) signal activation based on IPA analysis. Consistent with the 3ʹREADS analysis results,
UV treatment induced the formation of intron-APA transcripts that were polyadenylated (Figure
9C). Of the genes tested, I also saw that intron-APA isoforms levels were back down to basal
levels by 10 h after UV treatment, a recovery time seen to restore normal CpA (Kleiman and
Manley 2001). Thus, my studies indicate that induction of intronic APA is a consequence of
DDR of transient nature and its activation/suppression cycle coincides with DDR-mediated
regulation of CpA, suggesting a possible role for these intronic APA events in controlling gene
expression during DDR.
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Gene

Function

APA Direction

DUSP6 (Bagnyukova et al. 2013; Ma et al.
2013)

Phosphatase

Lengthening

NOTCH1 (Garcia et al. 2013; Vermezovic et al.
2015)

Membrane Receptor

Lengthening

SNRNPB2 (Folco et al. 2011; Sundaramoorthy
et al. 2014)

Splicing Factor

Shortening

KDELR1 (Smith et al. 2000; Hou et al. 2015)

Golgi Receptor

Lengthening

POLR2A (Yao et al. 2007; Heine et al. 2008)

Transcription Component

Intronic

CDKN1A (Garner et al. 2008; Prives and
Gottifredi 2008)

Cell Cycle Inhibitor

Intronic

EFNB2 (Genander et al. 2010; Wang et al.
2010)

Receptor Tyrosine
Kinase

Intronic

Transcription Factor

Intronic

Phosphatase Inhibitor

Intronic

E2F1 (Tort et al. 2006; Qi et a. 2015)
DSCR3 (Li et al. 2015; Preker et al. 2015)

Table 1: List of genes validated for APA after UV damage by qPCR analysis.
Listed at the left is the annotated gene name, following by its generally accepted
function. In the last column is indicated whether the effect of UV is on
lengthening/shortening the transcripts 3’UTR or APA usage within an intron.
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Figure 9: UV promotes alterations in both 3’UTR- and intron-APA. A) Schematic of
primer design. For intron-APA, forward primer was in exon 1 and reverse primers were
downstream of exon 1 either within intron 1 for short isoform or in exon 2 for canonical
mRNA. For 3’UTR APA, forward primer was ~50 nt upstream of proximal poly(A) signal
site and reverse primers were also upstream of proximal poly(A) signal for total 3ʹUTRAPA detection or immediately downstream of proximal site for distal site usage. B) qRTPCR analysis of HCT116 samples for the effect of UV on 3’UTR poly(A) signal choice.
The ratio of distal/proximal of each analyzed gene is shown. Samples were analyzed as
in (A) and monitored after the recovery for either 0.5 or 2 h after UV treatment. The qRTPCR values were calculated from three independent biological samples by triplicate. C)
Intron-APA is regulated on time dependent manner after UV treatment. Samples were
analyzed as in (B) but the ratio intron/full-length of each mRNA is shown.
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Next, I was interested to determine whether suppressing intronic APA events has any
cellular effect. Intronic APA of a CpA factor has previously been shown to affect gene
expression (Pan et al. 2006). Data from Dr. Devany (Kleiman’ lab) showed that functional
depletion of U1 snRNA, but not U2 snRNA, increases intronic poly(A) signal usage, and that
overexpression of U1 RNA diminishes UV-induced intronic APA. To further understand the
cellular consequences of the U1 snRNA-mediated control of intronic poly(A) signal usage I
overexpressed U1 snRNA in HCT116 cells to suppress UV-induced intronic APA (Devany et al.
2016) and then analyzed the apoptotic response. I analyzed the apoptotic response by
examining fragmented DNA in cytoplasm using enzyme-linked immunosorbent assay (ELISA),
as fragmentation of nucleosomal DNA has been described to occur during early apoptosis
(Gavrieli et al. 1992; Nagata 2000). Samples from cells transfected with empty vector were used
as control for apoptotic effect of the transfection procedure. While samples from cells
transfected/non-transfected with empty vector and treated with UV showed a ~2x fold increase
in DNA fragmentation, interestingly, overexpression of U1 snRNA abrogated the apoptotic
response (Figure 10). Thus, my data indicate that UV-induced usage of intronic poly(A) sites by
the downregulation of U1 snRNA levels might play a role in apoptotic response during UVinduced DDR.

Discussion

In this Chapter, I have confirmed our bioinformatic data showing that APA occurs in
individual genes after DNA damage in mammalian cells (Devany et al. 2016), affecting multiple
functions in myriad pathways associated to the DDR. I have also shown data that suggests that
there is bias towards activation of intronic poly(A) usage compared to repression, and that UVmediated increase in intronic APA events by U1 snRNA depletion might have a role in the
apoptotic response of cells after damage, as I observed that a decrease in the usage of
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promoter- proximal poly(A) sites by overexpressing U1 snRNA abrogated apoptosis after UV
treatment.

Figure 10: U1 snRNA overexpression suppresses UV-mediated apoptosis in
HCT116 cells. After 24 h of U1 snRNA overexpression, cells were exposed to UV
treatment followed by 6 h recovery. Cells were then counted and subjected to
ELISA (Roche) to measure DNA fragmentation. Data is the result of three
independent replicates. The qRT-PCR values were calculated from three
independent biological samples by triplicate.

The examples I validated of 3’UTR APA are genes found in a number of different
pathways, many of which are not directly related to DDR. In these instances, it is likely that the
different sizes of the 3’UTR are serving to either a) downregulate mRNA and thus protein
abundance, or b) to upregulate mRNAs for genes that can regulate proteins involved in
proliferation and cell cycle progression, such as phosphatases and trafficking proteins. It is also
of worth noting that these examples of APA are indeed due to selection of different poly(A)
signals giving a greater variety of 3’UTR composition and regulatory capacity, rather than
alternative cleavage sites from the same poly(A) signal (Pauws et al. 2001), where the
sequence variety would be only a few nucleotides. As the effect of U1 snRNA on APA is
dosage-dependent, and given that the observed 3’UTR APA events included both lengthening
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and shortening of transcripts, it is likely that U1 snRNA is not the primary only global regulator of
distal/3’UTR APA. Also noting that 3’UTRs are globally shortened in a cancerous cellular
environment (Mayr and Bartel 2009), it can be postulated that some tumor suppressor genes
may play a role in regulating the usage of distal poly(A) signal keeping the 3’UTRs of protooncogenes long so that they may be regulated more extensively, for example, by microRNAs.
Early research on APA determined that many sites of CpA were in fact non-canonical
poly(A) sites; sites less efficiently recognized and utilized by the CpA machinery and, in some
instances, sites with no detectable poly(A) hexamer (Tian et al. 2005). As intronic
polyadenylation is likely to be flanked by splice sites in a multi-exon gene, there are certain
correlations between the strength of splice and poly(A) sites (Tian et al. 2007). For example,
intronic poly(A) signals used that resulted in an extension of the previous exon (composite APA)
are generally weaker and, thus, less conserved (eg. AUUAAA) than when an alternative last
exon (skipped exon APA) are used. In my research, I observed a similar trend, whereby
POLR2A, an example of composite APA, has a weak poly(A) signal. On the other hand,
CDKN1A, a predicted example of skipped exon APA, had a strong poly(A) signal. This has two
immediate implications. Firstly, this is highly relevant as to whether these shortened transcripts
might possess any functional capacity; it is possible that intronic APA transcripts have the
potential to generate a new protein product or, alternatively, those shorter transcripts might
represent simply a fast way of regulating gene expression under changing cellular conditions,
with no functional role. In the last scenario, intronic APA might resemble deadenylation as a
mechanism of regulating gene expression. Secondly, U1 snRNA as a global regulator of APA
might also balance the selection of splice and poly(A) sites. For example, as weaker poly(A)
signals are much easier to suppress from CpA machinery, it is thus likely that different factors
are necessary to suppress strong poly(A) signals to allow the generation of intronic APA
transcripts. The rest of my thesis will attempt to characterize and determine the mechanistic
aspects of these two points.
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Research on the role of U1 snRNA in cell death is few and far between, but some
observations have been made. For example, a mutated U1 snRNA with different binding
patterns drove an increase in apoptosis (Jankowska et al. 2008). Interestingly, a study showed
that apoptosis induced through activation of the Fas plasma membrane receptor, known as the
extrinsic pathway, caused an endonucleolytic cleavage of the 5’ end of mature U1 snRNA partly
mediated by caspases (Degen et al. 2000). The sequences in the 5’ end of U1 snRNA are
responsible for base pairing with the nascent mRNA, so removal of this sequence would
ultimately inhibit both splicing and promoter-proximal polyadenylation. A cleaved U1 snRNA at
the 5’ end can compete with full-length U1 snRNA to form an inactive spliceosomal complex as
well as lose its ability to inhibit poly(A)polymerase (Gunderson et al. 1998), affecting the balance
to select either a splice or poly(A) sites. Other groups have found that aberrant levels of U1
snRNA can decrease its function in neural cells and that overexpression actually induces
apoptosis (Cheng et al. 2017). However, the same group found that in cancer cells high levels
of U1 snRNA do not significantly affect expression of a subset of apoptotic genes, while U1
snRNA knockdown induced cell death (Cheng et al. 2017).
Consistent with this group findings, I also did not observe a difference in apoptosis by U1
snRNA overexpression before UV treatment in cancer cell lines In relation to our model system,
as I was combining overexpression with UV, it is feasible that the overexpression effect is being
buffered by the endogenous reduction seen after UV damage (Eliceiri and Smith 1983; Devany
et al. 2016). Like that group, I also did not observe a difference in apoptosis before UV, as I was
also using cancer cell lines. When I included UV treatment to the overexpression studies, there
was modulation of U1 snRNA levels by endogenous and exogenous sources. In those
conditions, it is unclear whether Like that group, I also did not observe a difference in apoptosis
before UV, as I was also using cancer cell lines the source of cell death inhibition was due to
inhibited promoter-proximal APA or recovered splicing patterns. However, it has been shown
that regulation of APA requires a smaller change in U1 snRNA levels than inhibition of splicing
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(Berg et al. 2012). Consistent with this, our study did not show an increase in the inclusion of
introns located downstream of intronic poly(A) site APA after UV treatment (Devany et al. 2016),
suggesting that UV-induced decrease in U1 snRNA levels was not sufficient to inhibit splicing.
Thus, I suggest the effect on apoptosis is indeed due to modulated APA. The rationale is that
APA transcript(s) are modulating the apoptotic response and playing a part of DDR, rather than
existing as transcriptional artefacts during DNA damage.
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CHAPTER IV
INVESTIGATING RNA PROCESSING AND PROTEIN-CODING CAPACITY OF AN
INTRON-APA TRANSCRIPT FROM CDKN1A
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Background

Splicing and polyadenylation are both prevalent in genes because they generate
alternative RNA isoforms (Tian et al. 2005; Zavolan and van Nimwegen 2006). The dynamics
and order of these mechanisms in relation to transcription have been the subject of intense
speculation and research (Bentley 2014). For example, usage of multiple RNA-seq methods
identified that the majority of splicing occurs while the RNA is still tethered to the RNAP II
ternary complex, where RNAP II is only 100 nucleotides downstream of the 3’ splice site (ss)
and, hence, is co-transcriptional (Oesterreich et al. 2016). This study used budding yeast, which
prevalently possess only one intron, and thus limited alternative splicing. As budding yeast does
undergo APA (Liu et al. 2017) and the distance between the splice site and the poly(A) can
differ, considerable research has investigated the coordination and competition of splicing and
polyadenylation, where site selection can be promoted or antagonized by the contrasting
pathways, in this organism model. As discussed in Chapter III, CpA reaction can be negatively
regulated by 5’ss splicing components (Gunderson et al. 1998) as well as the introduction of a
canonical 5’ss close to and upstream of poly(A) signal (Niwa et al. 1992). Intriguingly, in stark
contrast, the presence of a 3’ss close to a poly(A) signal can promote polyadenylation (Cooke
and Alwine 1996). A 5’ss downstream of a poly(A) signal can also activate CpA in conjunction
with polypyrimidine tract binding (PTB) protein (Lou et al. 1996). Splicing activators, such as
TRAP150, that interact with the core spliceosomal machinery have been implicated in a dual
splicing/APA role (Lee and Tarn 2014).
The transcription process itself can play a major role in splicing decisions. It has been of
interest to determine how quickly splicing can occur during transcription i.e is splicing
completely post-transcriptional, that is, occurring after transcription and CpA have taken place?
Or is splicing co-transcriptional, that is, taking place during transcription and before CpA? The
relevance of these questions is in by knowing the sequence of events, one can infer the
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determining factor for each of these events, i.e which process is epistatic to which? Whether
splicing is co- or post-transcriptional affects the pathways that the splicing reaction can be
coupled with i.e transcription/polyadenylation or stability/nuclear export, respectively (Hansen et
al. 2018).
One of the earliest examples depicting splicing as co-transcriptional are the electron
micrograph images showing ribonucleoprotein deposition and looping during RNA synthesis in
vitro (Beyer and Osheim 1988). Using budding yeast, it was estimated that the majority of
splicing is post-transcriptional by the detection of U2 snRNP-associated pre-mRNA (Tardiff et al.
2006). In contrast, using nascent RNA single-nucleotide resolution assay to determine the
distance between splicing and RNAPII, the distance estimated that exon ligation occurs from
RNAP II is only a ~24 nt downstream of the 3’ss (Oesterreich et al. 2016). It is important to note
that certain genes can be spliced post-transcriptionally via a slow or inefficient reaction (Wallace
and Beggs 2017).
Cellular stress can affect these mechanisms. In mammalian cells, heat shock inhibits
post-transcriptional splicing in order to repress translation and downregulate gene expression
(Shalgi et al. 2014). It has also been shown that UV-mediated damage affects RNAP II
elongation rates regulating alternative splicing (Muñoz et al. 2009). While slow elongation could
permit splicing factor recruitment (Kornblihtt et al. 2013), slow elongation also permits
recruitment of a U2 snRNP binding competitor and promote skipping (Dujardin et al. 2014).
Hence, the detection and decision of exon definition is complex and dynamic, even without
considering APA.

Results

As described in Chapter III, work from our lab in collaboration with Dr. Tian (Rutgers
University) using a high-throughput sequencing strategy indicated a 2-fold increase in promoter49

proximal intronic poly(A) site selection (intron-APA) in cells treated with UV radiation. These
studies prompt the question whether these APA-transcripts are involved in the DDR. One of the
genes undergoing intron-APA include CDKN1A, encoding p53 transcriptional target CDKN1A.
To understand the extent of RNA processing the CDKN1A intron-APA transcript undergoes
under DNA damage, I first examined CDKN1A gene using the UCSC Genome Browser
(Karolchik et al. 2007). As Figure 11A shows, a predicted transcript with two exons with the
same transcription start site as canonical CDKN1A mRNA exists but with an alternative last
exon terminating at a poly(A) signal in intron 1. Importantly, the poly(A) signal used in this
predicted shorter transcript is the same determined to be used after UV treatment by our
bioinformatic data (Devany et al. 2016). This predicted transcript was first annotated manually
by the Human and Vertebrate Analysis and Annotation (HAVANA) group of the Vertebrate
Genome Annotation (VEGA) project from an expressed sequence tag (EST) (Ashurst et al.
2005). To date, no experimental research has been done on the existence or function of this
alternative transcript.
Using the strategy described in Figure 11B, my data indicate that the CDKN1A intronic
transcript undergoes splicing. A band corresponding to transcription of the entire region (~2,000
bp) between the primers was detected (Figure 11C). As the samples were treated with DNase I,
the observed band was probably not due to amplification of genomic DNA. The amplification
could correspond to either unspliced full-length pre-mRNA, as pre-mRNA can be detected by
RT-PCR (Lysenko et al. 2013), or intron-APA transcript. However, the usage of oligo(dT) primer
for cDNA synthesis makes the detection of pre-mRNA unlikely. Interestingly, only after UV
treatment, the appearance of a smaller isoform (~500 bp) corresponding to the size predicted by
the genome browser of a splicing event (Figure 10A) was detected (Figure 10C). Sanger
sequencing of the amplified fragment confirmed the presence of a canonical and, hence, strong
3’ splice site upstream of the poly(A) site (Burset et al. 2000). Thus, my data indicate that the
intronic transcript generated from CDKN1A under stress conditions can undergo an alternative
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splicing event using a strong splice site within intron 1 located upstream of the alternative
poly(A) signal.
There are three conceivable possibilities for the generation of the spliced CDKN1A
intronic transcript; either the splicing event is concomitant with intron-APA, or the alternative
exon is spliced to the next exon downstream as part of the full-length mRNA, or a combination
of both strategies can be utilized based on the conditions, such as transcriptional kinetics as
described by Kornblihtt and colleagues (2013). To further analyze this I performed 3’ rapid
amplification of cDNA ends (3’RACE) on RNA samples from UV-treated HCT116 cells. 3’RACE
allows to determine the location of 3’ end of an RNA to be elucidated using oligo(dT) primer for
cDNA synthesis with an adaptor sequence to act as reverse primer for PCR. In samples from
non-treated cells, using oligo(dT)-primer-adapter and forward primer in exon 1, I was able to
detect the polyadenylated/spliced CDKN1A intronic APA transcript with a 3’ end corresponding
to the location predicted by 3’READS data (bad of ~350 bp, Figure 12). After UV treatment, the
intensity of the band increased, supporting the 3’READS data that showed an increase in the
usage of this poly(A) signal in intron 1 of CDKN1A. An additional band of higher molecular
weight (~500 bp) was detected after UV treatment that might be generated from a second
priming point during PCR, suggesting that the RNA template might have longer poly(A) tail to
prime off. Thus, my studies indicate thatCDKN1A intronic transcript is both spliced and a bona
fide product of APA from CDKN1A gene.
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Figure 11: CDKN1A Intron APA transcript undergoes splicing. A) UCSC Genome Browser
indicates an annotated transcript terminating at intron 1 (maroon diagram at the bottom). This
intron-APA uses the same poly(A) signal in intron1 that the transcript detected via 3’ READS
technique in samples from HCT116 cells treated with UV and allowed to recover for 2 h (20
J/m²). Detection was scored in Reads Per Million (RPM), calculated as the number of poly(A)
site supporting (PASS) reads of that site in a million unique PASS reads per sample. Blue peak
indicate CpA detected before UV using 3’READS, red peaks are CpA detected after UV
treatment. Maroon boxes are exons and serrated lines are introns. The light blue area shows
the length of the expected intronic transcript. Green diagram at the bottom of the figure is the
phylogenetic analysis for coding region of the CDKN1A gene. Peaks facing upwards indicate
conserved coding regions. B) Schematic of PCR strategies to detect splicing in CDKN1A APA
transcript. Forward primer was in exon 1 and reverse primer in alternative last exon (“APA
exon”). Isoform distinction is based on molecular weight. C) Experimental confirmation of
splicing in CDKN1A intron transcript. HCT116 cells were treated with UV (20 J/m²) and allowed
to recover for 2 h, and then harvested. cDNA was prepared using oligo(dT) primers from nuclear
RNA and used for PCR reaction described in (B). A representative gel from three independent
samples is shown.
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Next, I was interested to determine the protein-coding potential of this CDKN1A APA transcript.
In many instances, intronic polyadenylation occurs downstream of intron and, thus, the APA
transcript contains much of the protein coding sequence, usually producing truncated isoforms
with varied or antagonist functions (Thomas et al. 2007; Mueller et al. 2016). However, we found
APA was overrepresented genome wide in the first intron after UV treatment in mammalian cells
(Devany et al. 2016). For example, the APA transcript for POLR2A, encoding Rpb1, occurs in
intron 1, but has protein-coding sequence beginning upstream in exon 1. The shorter transcript
from POLR2A has the potential to generate a protein product with an extremely truncated Nterminal fragment and unknown function. Interestingly, the canonical AUG for CDKN1A mRNA
begins in exon 2 (El Deiry et al. 1993), meaning that the APA transcript does not include any
canonical CDKN1A coding sequence (phylogenetic diagram at the bottom of Figure 11A). As
shown in Figure 13, both cell culture-based (panel A) and in vitro (panel C) translation assays
failed to detect a protein product for either the unspliced or spliced isoforms, despite high levels
of expression of both RNAs (Figure 13B). To confirm that the DNA preparation for the APA
isoforms did not contain an inhibitor of the translation reaction, I performed the reaction with a
mix of T7-driven plasmids containing HuR and either spliced or spliced/unspliced APA
transcripts. As shown in Figure 13D, translation of HuR was detected discarding the possibility
of an inhibitory impurity.
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Figure 12: 3’ rapid amplification of cDNA ends (3’RACE) gives experimental
evidence of an endogenously utilized polyadenylation site within intron 1 of
CDKN1A. Nuclear RNA from HCT116 cells was reverse-transcribed using an
oligo(dT)-anchor primer and amplified using a forward primer that hybridizes with
exon 1 and as reverse primer an equivalent to the adaptor sequence without the
oligo(dT) sequence. Positive control for this experiment was luciferase mRNA
provided by the kit (Invitrogen). The products were separated on an agarose gel
and detected by ethidium bromide staining. A representative gel from three
independent assays is shown. Molecular weight standard (MWS, 100-bp ladder
from Promega) is also included
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To explore the potential mechanism(s) involved in the generation of this APA event in
CDKN1A, first, I determined how conserved is this poly(A) signal evolutionarily. Are there
particular groups of organisms that have this APA event in common? To answer these
questions, I analyzed again the UCSC genome browser. As shown in Figure 14A, CDKN1A
intron-APA signal is found in old world monkeys, primates, and humans (catarrhines). The
sequence is slightly divergent, usually by one or two nucleotides, in new world monkeys, and
diverges more amongst the other mammals. The alternative hexamers found do not correspond
to any of the numerous redundant, less efficient poly(A) signals that exist (Tian et al. 2005). In
some mammals, such as rodents, as well as the rest of the animal kingdom, the hexamer and
surrounding sequence possess no synteny with the human one. This leaves only one likely
possibility: that the intronic APA in CDKN1A signal originated after the emergence of new world
monkeys approximately 35 million years ago (Ma) (Schrago and Russo 2003; Bond et al. 2015).
This finding is in line with the explosion in the number of long non-coding RNAs that have
emerged specifically in primates (Awan et al. 2017). In contrast, a protein-coding sequence and
canonical poly(A) signal corresponding to p21/CDKN1A is present in all mammals (Figure 14B),
which are currently estimated to have diverged approximately 300 Ma (Kemp 2006). It is worth
noting that organisms such as zebrafinch and chicken possess synteny for the coding sequence
for p21 protein, but that the genomic context is entirely different.
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Figure 13: Ex vivo and in vitro translation reactions yield no detectable protein product for both
spliced and unspliced CDKN1A APA isoforms. A) Overexpression of CDKN1A APA transcripts
make no detectable protein in HCT116 cells. CMV-driven expression plasmids with N-terminal
FLAG tags containing no transcript, GDP1 as positive control, or either spliced/unspliced APA
transcripts were overexpressed. Total protein was extracted from transfected cells and
immunoassayed with anti-FLAG antibodies. (*) indicates non-specific band detected by the
antibody. A representative gel from three independent samples is shown. B) High levels of spliced
and unspliced CDKN1A APA RNA are detected in transfected HCT116 cells. Total RNA samples
from cells transfected as in A) were analyzed by qRT-PCR using the strategy described in Figure
11B for spliced isoform. For unspliced isoform, the reverse primer was in closer proximity to exon 1
to allow for qPCR limitation of detecting amplicons <500bp. Errors represent the SD derived from
three independent experiments. C) In vitro translation reactions yield no detectable protein for
CDKN1A APA transcripts. T7-driven plasmids containing HuR as a positive control or either
spliced or spliced/unspliced APA transcripts were in vitro translated in rabbit reticulocyte lysates.
Translated proteins were labelled with biotinylated lysines, reactions were run on SDS-PAGE and
immunoassayed against

streptavidin-HRP conjugates.

A representative gel from three

independent samples is shown. D) In vitro translation as in (C) combining T7-driven plasmids
containing HuR and either spliced or spliced/unspliced APA transcripts.
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Figure 14: Comparative analysis of the poly(A) signal for intron-APA transcript and
canonical CDKN1A mRNA. Bar above each analysis represents the transcript for
which the comparative analysis is examining. Blue and red bars indicate 3’READS
CpA detection before and after UV treatment, respectively. Highlighted light blue area
indicates the poly(A) signal aligned for each species. A) APA analysis. B) canonical
poly(A) analysis.
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Discussion

In this chapter, using 3’RACE assays, I have provided biochemical evidence that the
CDKN1A intron-APA transcript detected originally by bioinformatic and qRT-PCR analysis
(Devany et al. 2016) contains a bona fide poly(A) site, which usage is upregulated after UV
treatment. In addition, I have shown that the transcript exists as two forms, a ~2 kbp unspliced
form, as well as a ~500 bp spliced isoform. The sequencing of the spliced transcript confirmed
that the splice site is annotated in the UCSC browser (transcript ID: ENST00000462537),
indicating that CDKN1A intron-APA transcript might undergo skipped terminal exon APA. This
alternative exon has an AG dinucleotide immediately upstream of the acceptor site and thus is a
canonical strong 3’ss (Burset et al. 2000). The presence of a canonical 3’ss suggests that the
splicing machinery could recognize this site, and that the site might be regulated through
elements or factors present during DDR, for example, splicing cofactors with affinity to an
intronic splicing silencer element (Carstens et al. 2000).
Recent research has uncovered a non-coding RNA generated after UV treatment from
within a protein-coding gene as a result of APA (Williamson et al. 2017). According to
GENCODE lncRNA catalog (Derrien et al. 2012), up to 4% of lncRNAs are intragenic intronic
sense-strand transcripts. Intriguingly, the coding region for CDKN1A mRNA begins in exon 2,
downstream from the intron-APA site. Using PhyloCSF browser tracks, which scores whether a
sequence represents a potential protein-coding region by multi-species nucleotide sequence
alignment (Lin et al. 2011), the high score for protein coding was seed in exon 2 of CDKN1A
(green diagram at the bottom of Figure 11A). However, no such score was detected for any
sequence of the intron-APA transcript. Interestingly, despite the low PhyloCSF score, an open
reading frame (ORF) was detected within exon 1, which represents a putative upstream ORF
(uORF) (Kim et al. 2012; Collier et al. 2018), and a STOP codon in the APA signal in intron 1.
The translation of such a transcript might lead to a ~16 kDa polypeptide. However, I was unable
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to detect any protein from CDKN1A intron-APA transcripts using ex vivo assays (Figure 13A).
To address the possibility that the lack of protein detection was not a result of some
endogenous cell regulatory mechanism, I also performed in in vitro translation assays (Figure
13C-D). Again, I was unable to detect any protein expression from CDKN1A intron-APA
transcripts using these in vitro assays. Consistent with this, BLAST analysis of the uORF
identified no known protein or protein domains.
Together, my data suggests that a spliced noncoding RNA is produced from an intronic
CpA event in CDKN1A after UV damage. It is possible that this RNA might translate into a short
peptide, and as many other lncRNAs (Ruiz-Orera et al. 2014), to interact with ribosomes
controlling gene expression. In fact, a previously annotated lncRNA was demonstrated to be
translated with cellular function (Matsumoto et al. 2017). Future experiments, such as ribosome
profiling, might offer further information of the translational capacity of this transcript.
Alternatively, to determine whether function is attributed to an RNA or protein, I could modify
CDKN1A intron APA RNA introducing an early STOP codon to prevent translation and
determine if function is affected.
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CHAPTER V
EXAMINING THE CONDITIONS AND FACTORS INVOLVED IN CDKN1A INTRON-APA
INDUCTION
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Background

As discussed in Chapters III-IV, my research has been focused in APA events induced
by DNA damage. Published ata from our lab has shown that much of the regulation of these
APA events is dictated by U1 snRNA abundance (Devany et al. 2016). Besides, those studies
showed that those APA transcripts can be detected between 2 and 6 h after UV treatment but
not at 10 h of the recovery time. The previous research was limited on analyzing only one dose
of UV treatment, only UV treatment with no other stressors tested, and only colorectal
carcinoma epithelium HCT116 cells. Protein interactors or regulators other than U1 snRNA were
also not determined. Therefore, I was interested in further understand how APA induction was
affected in other cellular conditions and environments, and what proteins may be involved in
APA regulation.
As extensively discussed in Chapter I, considerable research has already been
completed to identify APA regulators on a global scale. However, in my research, I was less
interested in the obvious candidates of APA regulation, such as cleavage factors, and more
interested in gene-specific examples that could be identified through sequence element
recognition, present either at the DNA or RNA level, in proximity to the intron-APA signal in
CDKN1A.
As the data presented in Chapter IV indicate that the CDKN1A intron-APA transcript has
the potential of being a lncRNA, investigating the regulation at the RNA level appeared to be
relevant. As both APA and canonical full-length transcripts use the same TSS, I also reasoned
that regulation of CDKN1A intron-APA that occurs at the DNA level by DNA-binding proteins
would more likely affect both transcripts induction. In contrast, sequence elements around the
intron-APA region recognized by RBPs would likely primarily regulate intron-APA transcript once
released from the chromatin. While an RBP that binds to CDKN1A intronic sequence upstream
of intron poly(A) site also has the potential to bind the canonical pre-mRNA, the binding of the
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RBP to the intronic APA transcript might occur first. This is because the CpA reaction of the
intronic site probably occurs before transcription of the entire CDKN1A gene has taken place i.e
co-transcriptional CpA. Supporting this, it has been shown that RNAP II CTD enhances
cleavage reaction while engaged in the transcription complex and that free RNA has low
cleavage efficiency (Adamson et al. 2005). As previously described (Kaida et al. 2010), it is
possible that any RBP investigated may impact the levels of APA in general and not exclusively
the levels of CDKN1A intron-APA.
Overall, in this chapter, I propose to test whether CDKN1A intron-APA transcript is
functional by elucidating any specificity in cellular conditions that allow its induction, as well as
resources that cell is spending to regulate APA expression.

Results

As previously mentioned, p53 is a transcription factor responsible for the damageinduced expression and repression of cell cycle and apoptotic genes (Farmer et al. 1992).
CDKN1A is one of p53 major targets through binding to response elements upstream of the
TATA box in the CDKN1A promoter (el-Deiry et al. 1993). Therefore, it was of interest to
determine whether p53 is involved in CDKN1A intron-APA induction. Using 3’READS assay in
samples from colon carcinoma RKO (p53 +/+) and RKO-E6 (p53 -/-) cell lines exposed to UV
treatment (20 J/m2), I determined that the level of CpA at CDKN1A intronic site was reduced in
samples from RKO-E6 compared to RKO before and after UV treatment (Figure 15). Extending
these studies, analysis of colon cancer HCT116 and p53-null HCT116 cell lines by qPCR
indicated a similar induction of CDKN1A intron-APA usage in a p53-dependent manner before
and after UV treatment. As previously described (Macleod et al. 1995), a modest increase in
CDKN1A full-length mRNA levels (compared to the APA transcript, Figure 15B) was observed in
cells expressing p53 after UV treatment. This minimal increase in CDKN1A full-length mRNA
62

levels was lost in p53-null HCT116 cells (Figure 15C). My results are consistent with previous
studies that showed that after UV treatment p53 recruitment increases at CDKN1A promoter at
a greater fold change rate than the induction of CDKN1A full-length mRNA (Magrini et al. 2007).
Together and as previously
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Figure 15: p53 is necessary for CDKN1A intron-APA induction. A) UCSC
Genome Browser view of detected poly(A) signal usage by 3’READS before and
after UV treatment at CDKN1A in samples from RKO (p53+/+) and RKO-E6
(p53-/-) cells. Intronic poly(A) signal are shown along with the canonical poly(A)
signal in 3’UTR. poly(A) signals are indicated, and their RPM values at different
time points are shown. At the bottom, maroon boxes are exons and serrated
lines are introns of expressed sequence tags (ESTs) from CDKN1A. B) and C)
qPCR analysis of CDKN1A intron-APA and CDKN1A full-length mRNA,
respectively, in samples from HCT116 and HCT116 p53-null cell lines. The
qPCR strategy used is described in Figure 9A. The qRT-PCR values were
calculated from three independent biological samples by triplicate.
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described (Devany et al. 2016), these results suggest that p53 expression may impact the
extent of CDKN1A intron-APA regulation.
To further understand the nature of the CDKN1A APA isoforms, I used an online
software named AnnoLnc, which provides expression profiles for lncRNAs based on compiles of
datasets from RNA-seq and CHIP-seq analysis, as well as information from other databases
and serves as a method of annotating novel RNAs (Hou et al. 2016). As a control RNA for
software analysis, I used the lncRNA HOTAIR. Several publications have described HOTAIR as
oncogenic (Hajjari and Salavaty 2015), including in breast cancer (Pawlowska et al. 2017). In
line with HOTAIR role in oncogenesis, the detectable expression profile of HOTAIR is
exclusively in cancer with higher expression in breast and lung cancer (Figure 16A)
The expression profile of the CDKN1A APA isoforms yields some interesting
observations (Figure 16B-C). First, both the unspliced and spliced transcripts have been
detected in various RNA-seq collections. Second, the expression of both CDKN1A APA
isoforms appears to have some tissue specificity, suggesting that this differential expression
might reflect the ratio of unspliced/spliced in different tissues. Further analysis of the expression
pattern of each isoform indicates that the expression of the CDKN1A spliced APA is abrogated
in cancers of both lung and lymph tissue (Figure 16C). For the CDKN1A unspliced APA, while
adrenal expression is also decreased in cancer cells, expression in kidney carcinoma and
melanoma is increased. It is worth noting that unlike the CDKN1A spliced APA and HOTAIR,
the unspliced APA transcript does not have a uniform direction of expression between normal
and transformed cells. Finally, it is important to highlight that the expression profile for both
CDKN1A APA isoforms may be underrepresented because our studies indicate that those
isoforms are expressed primarily during DDR (Devany et al. 2016). Besides, as CDKN1A is
developmentally regulated (Nayak et al. 2018), it is possible that intron-APA may also undergo
tht type of regulation.
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Figure 16: Expression profiles for lncRNAs in normal tissue and cancer samples
obtained from AnnoLnc software. A) Normal tissue and cancer expression for
HOTAIR lncRNA. B) Expression profile for CDKN1A unspliced intron-APA
transcript. C) Expression profile for CDKN1A spliced intron-APA transcript. FPKM
= fragments per kilobase of transcript per million reads. The cutoff of 1 indicated
by the red dotted line is set by AnnoLnc to determine fragment reads above
background.
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The metadata is interesting because it shows that other labs have also identified the
existence of CDKN1A APA transcript by using RNA-seq in a variety of cellular backgrounds. As
the program algorithm for AnnoLnc predicts the sequence of APA locus of sequences noncoding for protein, the inclusion of CDKN1A APA transcripts in this program supports my results
presented in Chapter IV. Those results indicate that CDKN1A APA transcripts are lncRNA
transcripts (Figures 13 and16). However, not all RNA-seq methods included in AnnoLnc are
selected for poly(A)+ RNA, and so it is possible that the RNA detected might be fragments of
pre-mRNA. As shown in Figures 11-12 and 14, the unspliced and spliced CDKN1A APA
isoforms can exist as polyadenylated transcripts in HCT116 cells.
To test whether CDKN1A APA exists and is induced in other cell types I used MCF7
breast cancer cells, which are wildtype for p53 to allow APA induction under DNA damaging
conditions. To examine whether APA induction occurred also in normal cells I analyzed nontransformed skin fibroblast BJ cells. BJ cells allowed me to compare APA induction in normal
cells and cancer cell lines. The results are shown in Figure 17. In HCT116 cells, UV treatment
induced both unspliced and spliced CDKN1A isoforms within 2 h recovery time after UV
treatment, where the unspliced is the precursor i.e pre-RNA of the spliced transcript. Full-length
CDKN1A mRNA was also significantly induced, but not to the degree of APA isoforms (Figure
17A). This is consistent with the results shown in Figure 14 B-C and previous studies (Macleod
et al. 1995) that showed a modest increase in CDKN1A full-length mRNA levels in cells after UV
treatment. As previously described (Chen et al. 2011), etoposide treatment (20 µM) for 18 h
strongly induced full-length CDKN1A mRNA. Interestingly, unspliced CDKN1A APA was also
induced strongly by etoposide, reaching levels approximately 30 fold more than untreated cells
and 2.5 fold more than UV treatment. Spliced CDKN1A APA was induced 11 fold more in
etoposide treatment compared to non-treatment, and 1.5 fold more compare to UV induction.
The greater induction of unspliced compared to spliced CDKN1A isoforms in samples from
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etoposide treated cells may represent a cellular cap for splicing activity during DDR. MCF7 cells
showed a slightly different behavior

Figure 17: CDKN1A APA isoforms and full-length expression in a variety of cell
lines and stressor conditions. Total RNA was purified from cell culture at 80%
confluency. cDNA was synthesized using oligo(dT) primers. qPCR was then
performed using primers to detect individual CDKN1A isoforms as depicted in
Figures 9A and 11B. A-C) Effect on CDKN1A isoforms of DNA damage agents in
different cell lines. Cell lines are indicated. The qRT-PCR values were calculated
from three independent biological samples by triplicate. (* p<0.05, ** p<0.005, ***
p<0.0005, **** p<0.00005).
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(Figure 17C), as induction of unspliced and spliced was similar after UV treatment, while fulllength mRNA underwent a slight decrease, in agreement with p21 induction delay during UV
response (Wang et al. 1999).
The non-cancerous BJ cells harbor some intriguing observations (Figure 17D). First, at
the same UV dose (20 J/m2) and recovery time (2 h) as the cancer cells, unspliced APA
increased approximately 3.5x, much lower than the increases seen for MCF7 (7.5x) and
HCT116 (8x). Second, the spliced APA isoform was not increased, suggesting that splicing of
unspliced APA transcript occurs earlier or at a faster rate in cancer cells than normal cells, or
that an inhibition of splicing that occurs during UV response in normal cells is lost or reduced in
the cancer cells. However, these possibilities are challenged when taking etoposide treatment
into consideration, as etoposide induced all APA isoforms as well as full-length mRNA. It is also
possible that transcription regulation of CDKN1A differs depending on stress and cell type. It
has been shown that CDKN1A transcription is regulated in a DDR-kinase CHK1 manner (Mattia
et al. 2007), where the distinction is whether full-length CDKN1A mRNA is immediately strongly
induced or not. Hence, the levels of unspliced APA transcript in normal cells may depend on
levels of activation of transcription by kinases activation. To summarize, APA can be induced in
a variety of cell lines, both cancer and normal. APA is also induced to varying degrees upon
stresses that have been shown to delay p21 induction. The rate of splicing also differs between
stresses and cell lines, and it is not clear whether all of the induced APA events are destined to
become spliced, or whether some unspliced RNAs remain stable in the cell.
Several studies have shown that CDKN1A undergoes stress specific gene expression
regulation at CDKN1A promoter (Gomes et al. 2006). The transactivation delay is at the level of
transcription elongation (Mattia et al. 2007) and is dependent on Chk1, which was uncovered
using chemical inhibitors of Chk1 as well as caffeine, which inhibits Chk1 activation (Lu et al.
2008; Beckerman et al. 2009). Inhibiting Chk1 during stresses that normally produce delayed
p21 induction restored RNAP II serine 2 phosphorylation, a marker for elongation, as well as
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increased CstF-64 recruitment to CDKN1A 3’ end, and restored CDKN1A full-length mRNA
upregulation.
It is possible that the observed inhibition of transcription elongation of the full-length
CDKN1A mRNA might be due to CDKN1A APA (Devany et al. 2016). I hypothesized that the
inhibition of transcription elongation is due to increased APA in the first intron of CDKN1A. To
test that I used the conditions described to rescue CDKN1A full-length mRNA induction
(Beckerman et al. 2009) by treating HCT116 cells with hydroxyurea (HU) with or without a 1 h
caffeine pretreatment to inhibit DDR kinase CHK1 activation. HU is a reversible ribonucleotide
reductase inhibitor that depletes deoxyribonucleotide pools, thereby inhibiting DNA synthesis
and mimicking DNA damage (Scully et al. 1997). If intron-APA plays a role in the inhibition of
CDKN1A full-length mRNA induction, rescuing CDKN1A full-length mRNA induction should
have an opposing effect on HU-mediated induction of APA. My observations are found in Figure
18.
While the HU treatment induced the p21 protein levels, the induction was lower than the
one observed after etoposide treatment (Figure 18A-B). As previously reported, caffeine
treatment rescued both CDKN1A full-length mRNA and protein induction to levels comparable
to etoposide (Beckerman et al. 2009). In contrast, caffeine pretreatment had a negligible effect
when combined with etoposide, a strong inducer of p21. HU, like UV treatment, induced the
levels of APA transcripts (Figure 18C). Interestingly, while both the levels of unspliced and
spliced APA transcripts increased during rescue with caffeine, the level of unspliced was
increased by a similar fold change relative to the control as the full-length mRNA. Thus, the data
suggests that rescuing CDKN1A transcription elongation does not downregulate APA induction
by stress conditions and, hence, that APA does not occur to prevent CDKN1A full-length
transcription elongation to 3’ end of gene.
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Figure 18: Rescuing CDKN1A full-lenght mRNA induction with caffeine
pretreatment does not abrogate DNA damage-induced APA. HCT116 cells were
treated or not with caffeine (4 mM) for 1 h before the media was replaced and
supplemented with HU (1.7 mM). After 24 h, either total protein or total RNA were
purified from the collected cells for analysis of p21 (A-B) and CDKN1A isoforms
(C), respectively. A) Lamin A was used as loading control in Western blot
analysis. A representative Western blot from three independent assays is shown.
B) Errors represent the SD derived from three independent experiments. C) qRTPCR analysis of APA isoforms and full-length mRNA of CDKN1A gene after HU
and/or caffeine treatments using total RNA samples. cDNA was synthesized using
oligo(dT) primers. qRT-PCR was then performed using primers to detect individual
CDKN1A isoforms as depicted in Figures 9A and 11B. The qRT-PCR values were
calculated from three independent biological samples by triplicate.
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Role of RNA-binding protein HuR on CDKN1A APA
The typical RNA-binding regulatory effects on APA are those produced by U1 snRNP on
promoter-proximal poly(A) suppression (Kaida et al. 2010; Berg et al. 2012). Some of the RBP
regulators of APA include core factors in the CpA reaction (Takagaki et al. 1996; Jenal et al.
2012). The effect of an RBP on APA can also be context dependent, as in the case of
polypyrimidine tract binding (PTB) protein (Moreira et al. 1998; Castelo-Branco et al. 2004), a
protein typically involved in splicing regulation. Recently, the RBP human antigen R (HuR) has
been described to play several roles in the regulation of different RNA-related mechanisms.
RBP HuR has roles in stability (Wang et al. 2000; Mazan-Mamczarz et al. 2003), splicing
(Izquierdo 2008; Akaike et al. 2014) and APA (Mansfield and Keene 2012). HuR role in APA
does not appear to be global (Kraynik et al. 2015) and its role in splicing appears to be limited to
cassette exons from data obtained (Mukherjee et al. 2011). HuR binding to RNA targets is also
affected by DDR (Abdelmohsen et al. 2007; Masuda et al. 2011; Zhou et al. 2013).
Because my investigation potentially is implicated in all of these processes, I was
interested to determine whether HuR might directly regulate CDKN1A APA. To test that I first
determine whether a predicted binding site for HuR is present in the CDKN1A APA isoforms. I
utilized a peer-reviewed program called RBPMap, which is a computational tool that enables
accurate prediction and mapping of RBPs binding sites on any RNA sequence (Paz et al. 2014).
As the APA transcript appears to exist as both unspliced and spliced isoforms, I analyzed both
sequences individually using RPBMap. Out of all the proteins predicted to bind, one of the most
statistically relevant was HuR. Interestingly, HuR binding was predicted for only the unspliced
isoform (Figure 19A) but not for the spliced isoform (data not shown). Specifically, two HuR sites
in close proximity were predicted. Previous data has indicated that 75% of transcripts have 2 or
more HuR binding sites (Mukherjee et al. 2011). When compared with the UCSC genome
browser, the HuR binding sites matched with a region of high, dense conservation among both
vertebrate and primate collections (Figure 19B).
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Then, it was of interest to establish whether HuR binds to CDKN1A APA isoforms, and
the dynamics of HuR binding to these isoforms during the progression of DDR. This was
achieved by a) modified RNA immunoprecipitation (RIP) assays using recombinant His-HuR
and total RNA from HCT116 cells exposed to UV treatment, and b) RNA pull-down assays with
biotinylated in vitro transcribed CDKN1A APA isoforms and NEs from UV-treated HCT116 cells.
Consistent with the RBPMap prediction (Figure 19A), binding of HuR was detected only for
unspliced but not spliced CDKN1A APA isoforms by RIP assays (Figures 20A-B). Full-length
CDKN1A mRNA binds to HuR by sequences present in the 3’UTR of the gene (Wang et al.
2000). Interestingly, HuR binding to APA isoforms is maintained during the progression of the
DDR (Figure 20C). Therefore, my data indicate that the binding of HuR to APA may be involved
in regulating APA and thus the progression of DDR.
After the validation of HuR binding to CDKN1A unspliced APA transcript via both
bioinformatic and biochemical approaches (Figures 19-20), I was interested to know whether
HuR expression levels might affect CDKN1A APA levels. Consistent with previous studies that
show that HuR is a ubiquitously highly expressed protein (Ma et al. 1996; Srikantan and
Gorospe 2012), samples from cells overexpressing HuR did not show significant changes in the
levels of CDKN1A isoforms (data not shown). This was also true when HuR was overexpressed
and cells were exposed to UV stress, consistent with prior reports that most stresses, including
UV, do not affect HuR abundance (Abdelmohsen et al. 2009). So then I decided to perform
siRNA-mediated knockdown of HuR rather than overexpression assays. Knockdown of HuR
(single-dose tranfection for 36 h) was confirmed by qRT-PCR and Western blot (Figure 21A-B).
The reduced level observed after UV treatment could be due to the export of HuR to the
cytoplasm (Westmark et al. 2005). Interestingly, HuR knockdown induced both CDKN1A APA
isoforms early in the recovery from UV treatment but had differerent effects on the levels of
unspliced and spliced isoforms at later times in the recovery (Figure 21C-D). This is unexpected
as HuR only binds to the CDKN1A unspliced APA isoform (Figure 19-20). However, levels of
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spliced isoform could occur due to changes occurring in the unspliced isoform, as the unspliced
isoform is the mandatory precursor from which the spliced isoform is derived.
To determine whether the effect of HuR on the levels of CDKN1A APA isoforms is
transcriptional or posttranscriptional (Mukherjee et al. 2011) I depleted the expression of HuR in
HCT116 cells with siRNA followed by UV and/or with actinomycin D (Act-D) treatment and
meassure CDKN1A APA isoforms levels. Act-D is thought to intercalate DNA and prevent
progression of RNA polymerases and, hence, inhibits transcription (Perry and Kelley 1970). I
used concentrations previously tested (Yoon et al. 2012). As CDKN1A APA is primarily induced
during DNA damage (Devany et al. 2016) and HuR appeared to bind more the unspliced APA
isoform during DDR (Figure 20), it was of interest to test the effect of independent HuRmediated transcription on CDKN1A APA during DDR. Therefore, prior to Act-D treatment, I
treated cells with UV, allowed them to recover for 2 h, and then either extracted RNA or added
Act-D for indicated time points (diagram in Figure 22A). Therefore, transcription had been active
for only 2 h post-UV treatment for each time-point indicated.
As a non-HuR target gene and due to its long half-life (Wang et al. 2000), the RNA levels
for GAPDHwere unaffected by either HuR knockdown or Act-D (Figure 22B). Surprisingly, the
spliced APA isoform was similarly unaffected once transcription had been inactivated,
suggesting that the spliced isoform is a particularly stable poly(A)+ lncRNA. The RNA levels of
the CDKN1A spliced form were also not affected significantly by HuR knockdown. This is
consistent with the results shown in Figure 19-20 that indicate that the spliced form does not
bind to HUR. would be predicted as binding of HuR to the isoform was not observed (Figures
19-20. Interestingly, the CDKN1A unspliced APA isoform underwent Act-D-mediated decrease
in RNA abundance, with a half-life of approximately 3 h, suggesting that the unspliced is less
stable than its spliced counterpart. Knockdown of HuR further decreased the half-life of the
unspliced in a UV background. Together, these results indicate that HuR plays a direct role in
regulating the levels
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Figure 19: Predicted HuR binding site overlaps with a dense conserved region in
CDKN1A intron 1. A) CDKN1A unspliced APA isoform was analyzed by RBPMap
program and given Z-scores, which represents the derivation of the mean
predicted binding for a series of randomly selected exonic and intronic elements,
for sequences matching degenerate HuR motif. B) RBPMap data was aligned to
UCSC genome browser. Vertical teal lines in blue indicate the predicted HuR
binding sites. Black boxes represent exon 1 (left) and the alternative exon (right),
and thin black line is intron 1 sequence emcompassing APA transcript within
CDKN1A APA isoform. Dark green peaks show primate conservation of regions
in the CDKN1A intron-APA transcript.
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Figure 20: HuR binds to unspliced but not spliced CDKN1A APA isoform. A) Total
RNA from HCT116 cells was incubated with recombinant His-HuR protein and
immunoprecipitated with either antibodies against His-tag or control IgG. Then qRTPCR analysis was performed for CDKN1A isoforms using primers to detect individual
CDKN1A isoforms as depicted in Figures 9A and 11B. Errors represent the SD (n =
3). B) RNA pull-down assays were performed using in vitro transcribed biotinylated
RNA from the CDKN1A APA isoforms mixed with NEs from HCT116 cells exposed to
UV treatment (20 J/m2). In vitro transcribed biotinylated Pet14-b RNA was used as
nonspecific sequence (no HuR sequence is present in this fragment), while RNA from
TP53 3’UTR was used as positive control for binding (Zhang et al. 2015). Lamin A
was used as negative control for binding. A representative pull-down reaction from
three independent assays is shown. Five percent of the NEs used in the pull-down
reactions is shown as input. C) RNA pull-down as in (B) except performed over a time
course of revovery after UV exposure. D) Quantification of RNA pull-down assays
represented in (C). The presented ratios were calculated for each samples related to
its own input.
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Figure 21: HuR expression leves affect the abundance of CDKN1A APA transcripts. A-B)
Validation of HuR knockdown by Western blot (A) and qRT-PCR (B). HCT116 cells (~5 x 105
cells per plate) were treated with either control (siCTRL) or HuR siRNA (200 pmols) and UV
irradiation (20 J/m2). Either nuclear protein or total RNA were analyzed for HuR expression
using anti-HuR antibodies or specific primers for HuR mRNA, respectively. A) Lamin A was
used as loading control in Western blot analysis. A representative Western blot from three
independent assays is shown. B) cDNA was synthesized using oligo(dT) primers. qRT-PCR
was then performed using primers to detect HuR. The qRT-PCR values were calculated from
three independent biological samples by triplicate. C-D) Levels of spliced (C) and unspliced (D)
APA isoforms are shown as the HuR siRNA/CTRL ratio. Values for the qRT-PCR for each
isoform were normalized to the ones of GAPDH. Samples were preared as in (A). The qRTPCR values were calculated from three independent biological samples by triplicate. E) qRTPCR analysis of CDKN1A isoforms from samples of cells treated with UV irradiation and
allowed to recover for 8 h, when APA levels decline and approach basal levels (Devany et al.
2016). Intron 2 is included as negative control for amplification. Full-length CDKN1A mRNA is
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included as positive control for effect of HuR siRNA-mediated depletion (Wang et al. 2000),
ubiquitin is included as loading control.

Figure 22: HuR regulates abundance of CDKN1A APA isoforms in transcriptionindependent manner. A) Schematic showing experimental design. The time
points are indicated by color-coding in panel B. B) mRNA decay rates for
CDKN1A APA isoforms and GAPDH, a non-HuR target gene, were determined
by qRT-PCR at different time points following HuR/control siRNA-, UV- and Act D
treatment. cDNA was synthesized using oligo(dT) primers. qRT-PCR was then
performed using primers to detect GAPDH and the APA isoforms with strategy
shown in Figure 11B. The RNA levels are expressed as a percentage of the
values detected for each RNA in the 2 h recovery post-UV treatment. The
percentages were calculated from three independent samples. Errors represent
the SD derived from three independent experiments.
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of CDKN1A unspliced APA isoform, but not the spliced isoform, which is the product of the
unspliced isoform, in a transcription independent manner by direct interaction of HuR with the
APA transcript during the progression of DDR.

p21-/- HCT116 cells
The Vogelstein group described for first time some of the functions of p21 by using cells
with an homozygous deletion in CDKN1A gene generated by homologous recombination
(Waldman et al. 1995). As all of the protein-coding sequence of p21 exists in exons 2 and 3, the
group recombined out only those regions, replaced them with resistance markers, and left the
rest intact, such as exon 1 and the majority of intron 1. Therefore, I hypothesized that CDKN1A
intron APA would be expressed in p21-/- HCT116 cells and possibly dysregulated due to the
recombination event that took place. As demonstrated in the original manuscript and others
(Chen et al. 2011), CDKN1A mRNA and p21 protein expression are entirely absent from this
cell line. Therefore, I performed qPCR to examine the abundance of APA transcripts in this
cellular background. My initial observations are found in Figure 23.
Unfortunately, although it appeared that APA isoforms were highly expressed basally in
the p21 knockout cell line and were additionally induced after UV treatment, qRT-PCR analysis
of full-length CDKN1A mRNA indicated presence of such mRNA in levels lower than the
detected in the parental cell line and unaffected by UV irradiation. Therefore, I could not be
certain that APA was indeed more highly expressed in a p21-/- background. As the negative
control samples to account for contamination of tubes, reagents, or pipettes came up with no
amplification (not shown), I concluded that the cell line themselves were harboring p21+/+ cells.
A second order from the Johns Hopkins repository produced similar results. According to the
literature, this concept of cell line to cell line contamination is not a rare or new issue (NelsonRees et al. 1981; Lucey et al. 2009; Serge and Halffman 2017). To purify the cell line I
performed two-step antibiotic selection of groups of 5,000 cells, comparing how the p21-/- cell
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line responded versus the parental HCT116 line, which are not resistant to either G418
(neomycin) or hygromycin B. I used

Figure 23: Levels of CDKN1A APA isoforms are higher in p21-/- cells compared
to the parental cell line. A-C) Cells were cultured to ~85% confluency and then
dosed with UV irradiation (20 J/m2) and allowed to recover for 2 h before total
RNA extraction. cDNA was synthesized using oligo(dT) primers. qRT-PCR was
then performed using primers to detect individual CDKN1A isoforms as depicted
in Figures 9A and 11B. The qRT-PCR values were calculated from three
independent biological samples by triplicate. D) Following double antibiotic
selection (post-drug), cells were RNA extracted and subjected to qRT-PCR for
full-length and spliced CDKN1A transcripts as in (A). The products were
separated on an agarose gel and detected by ethidium bromide staining. A
representative gel from three independent assays is shown. E-F) Following
double antibiotic selection (post-drug), cells were RNA extracted and subjected
to qRT-PCR for individual CDKN1A isoforms as in (A). The qRT-PCR values
were calculated from three independent biological samples by triplicate.

80

the antibiotic concentrations described by the original manuscripts (Waldman et al. 1995). After
3 days, all of the HCT116 parental cells were dead, whereas the p21-/- were viable and growing
for 10 days of G418 treatment and a subsequent 10 days of hygromycin B treatment. Following
the treatments, I extracted the RNA and performed qRT-PCR, comparing the sample to both
HCT116 cells as well as the p21-/- pre-drug treatment (Figure 24D). I observed that the
abundance of mRNA detected pre-drug treatment was ablated, thus a cell culture contamination
was the most likely primary source of full-length CDKN1A mRNA detected. In the absence of
full-length CDKN1A mRNA expression, the levels of spliced CDKN1A APA increased after drug
treatment, as a greater proportion of the cells were now fully isogenic for p21 deficiency.
However, unspliced CDKN1A APA levels appeared to be decreased. It is possible that in a
situation where the full-length mRNA exons (exons 2 and 3 have been removed, that the
retained APA transcript is now bias towards splicing, for example if the splicing components
recruited to CDKN1A that would have been otherwise used for exons 2 and 3 splicing, are now
available to increase the splicing of APA transcript instead.

Discussion

The studies presented in this Chapter showed that CDKN1A APA induction is tightly
linked with the regulation and expression of other key DDR factors, such as p53 and HuR
(Figure 15 and 22). Besides CDKN1A APA can be observed to be induced in a number of
different cell lines of both tumorigenic and normal origin in a non stress-specific manner (Figure
17). Rescuing CDKN1A gene from transcription elongation inhibition with caffeine, I observed
that the expression of both intronic APA isoforms and full-length mRNA correlate (Figure 18).
Finally, I observe a direct binding and regulation of APA isoforms by the RBP HuR (Figure 20).
The results of partial p53-dependence on CDKN1A intronic APA is not surprising, given
that full-length CDKN1A mRNA induction after stress is p53 dependent (Macleod et al. 1995).
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However, the qRT-PCR (Figure 15) and 3’READS (Devany et al. 2016) data produces a
disparity with one another in that CpA at canonical site appears to be higher after UV in RKO-E6
(p53 deficient) cells compared to parental RKO cells. In Figure 15, qRT-PCR data of HCT116
cells shows that full-length CDKN1A mRNA is higher in parental cells compared to p53 deficient
cells. This discrepancy could be explained by the different ways in which p53 expression is
prevented in these two cell lines. RKO-E6 expresses human papillomavirus E6 protein which
forms complex with p53 and targets it for rapid degradation (Thomas et al. 1999), whereas
HCT116 p53 -/- cells are homozygous knockout. Thus the difference in cell line usage between
bioinformatic and biochemical detection methods may be a factor. Alternatively, the discrepancy
could be due to the differences in the method of detection, as 3’READS detects CpA events and
requires a much longer oligo(dT) primer than does qRT-PCR, which the latter then may be
enriching mRNAs with shorter poly(A) tails. For APA, as 3’READS data concurs with qPCR
data, it is likely that cell line difference or poly(A) tail length are not major factors.
The AnnoLnc datasets (Hou et al. 2016) are interesting in that they represent an external
source of detection of CDKN1A APA transcripts other than our lab. While the expression of the
RNA-seq datasets of either unspliced or spliced above the FPKM cutoff is limited to
approximately 2 tissue types in normal cells (Figure 16). This limited increase may be due to the
fact that these transcripts are induced rather than suppressed during DDR, and their expression
levels may have been higher should these tissue types be stressed. The qPCR data I obtained
from the cell lines available show that the cancer cells are generally more inducible for intronic
APA compared to normal cells (Figure 17). There are several possibilities for this. First, it may
be a difference in the source of the cell lines, as both the HCT116 and MCF7 cells that were
tested are from adult patients, whereas the BJ cells are neonatal. Importantly, all cell lines
tested are wild-type for p53. Second, it fits the model by which cancer cells generally undergo
more APA via transcript shortening compared to normal cells (Flavell et al. 2008; Mayr and
Bartel 2009) in a U1 snRNA-dependent manner (Kaida et al. 2010). The primary reason for this
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is unsure but may either be reduced U1 snRNA levels or increased transcriptional output in
cancer cells leading to reduced U1/transcript available (Berg et al. 2012). The third possibility is
that while cancer cells are more inducible than normal cells, the normal cells examined may
have higher basal expression of CDKN1A intron APA, which BJ cells appeared to when
normalized to housekeeping gene (Figure 17).
The positive correlation of full-length CDKN1A mRNA with APA induction is a surprising
finding (Figure 18C). At the beginning of this study, my hypothesis was that the selection of
CDKN1A mRNA canonical poly(A) signal was in competition with APA poly(A) signal, as would
be assumed to be the case for signals in the same transcriptional unit on the same strand. As is
previously described, caffeine (and hence Chk1 inhibition) rescues the transcription elongation
of CDKN1A (Mattia et al. 2007; Beckerman et al. 2009). Interestingly, rescuing full-length mRNA
induction with caffeine does not abrogate APA induction during DDR. It is unclear where exactly
the inhibition of elongation occurs. The Prives group (Mattia et al. 2007) did not detect any
difference in CDKN1A primary transcript levels for an intronic region corresponding to the
unspliced APA transcript studied here between HU and HU+Caffeine treatment. However, I
detected a strong increase in unspliced, and weaker for spliced, CDKN1A APA transcript upon
caffeine pre-treatment (Figure 18C). This may be due to the fact that the Prives group
synthesized cDNA using both oligo(dT) and random hexamers, and thus they would be
detecting the intron 1 region in pre-mRNA as well as APA. As I used only oligo(dT) primers, my
assays specifically detect intron APA transcripts.
As the amount of full-length CDKN1A mRNA via raw Ct values is approximately 100x
greater than the amount APA transcripts in unstressed cells (Table 2), the total transcription of
the full-length relative to APA is high. It is possible that unstable pre-mRNA intronic sequences
may be masking any increase in APA observed. Interestingly, an increase in serine 2
phosphorylation (Ser2p) of RNAP II CTD is detected downstream of APA site by ChIP assays
upon conditions that rescue transcription elongation of CDKN1A (Beckerman et al. 2009). It is
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also apparent from their ChIP data shows a 50% increase in RNAP II Ser2p at the poly(A) site
used in CDKN1A intronic APA. My data suggests that while upstream DDR kinases, such as
ATR and CHK1, can rescue the transcription elongation of full-length CDKN1A, those kinases
are not necessary for intron APA induction in stress conditions.

Ubiquitin C
Untreated 1

19.94808

Unspliced
CDKN1A
31.82752

Spliced
CDKN1A
31.80608

Full-length
CDKN1A
22.7532

Untreated 2

18.166122

30.9347

32.09334

22.96431

Untreated 3

19.235859

31.53358

32.54991

24.07069

UV 1

20.192856

28.50216

27.86771

23.28235

UV 2

19.733307

28.92945

29.37959

23.12796

UV 3

19.453285

28.54096

29.17277

23.03979

Table 2: Representative example of raw Ct values for control and CDKN1A
isoforms. Column 1 indicates each biological replicative of a sample. Each
proceeding column represents the Ct values derived for each primer set, indicated
in Row 1. Each Ct values is drawn from 2 technical replicates with standard
deviation <0.5. Each Ct integer represents a 2-fold difference.

One could assume that a conserved nucleotide sequence exists as such out of chance,
such as in a region with a very low spontaneous mutation rate or that it serves as a
recognizable region for RNA or protein docking factors, or that the conserved sequence serves
some topological function in relation to those docking factors. In the case of the particular
sequence within CDKN1A intron APA transcript, data suggests it serves partially as a docking
element for RBP HuR (Figures 20-22). My data shows binding of HuR to unspliced but not
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spliced CDKN1A transcript before UV treatment by both RIP of endogenous RNA as well as
RNA pull-down of endogenous HuR (Figure 20). After UV treatment, I consistently observed a
transient decrease in HuR binding to unspliced CDKN1A transcript at 2 h, but binding is
restored after 4 h (Figure 20C-D). Similar results were observed using HuR depletion approach,
HuR knockdown at 2 h recovery time post-UV treatment induced significantly both APA isoforms
and this is lost at 8 h for the unspliced form (Figure 21), indicating that binding of HuR to the
unspliced transcript plays role in its stabilization to recover the levels observed in untreated
cells. In order to understand the role HuR in CDKN1A APA, several observations need to be
taken into account. First, HuR is not binding to the spliced isoform and, thus, it does not directly
regulate spliced APA isoform levels. Second, the position of HuR binding to the unspliced is
relevant to inferring its function in the light of the data. Previous studies showed that HuR is
implicated in regulating APA of its own gene by binding in close proximity (less than 200 bp)
from the poly(A) signals (Dai et al. 2012). As HuR binding to the unspliced transcript is >1 kbp
from the poly(A) site used in APA and HuR has a transcription-independent effect on unspliced
APA transcript (Figure 22), I conclude that HuR is not likely to be directly involved on the CpA
event. Likewise, as with APA regulation, HuR regulation of splicing is dependent on sequences
in close proximity (20-100 bp) to the acceptor sites (Izquierdo 2008; Lebedeva et al. 2011).
Global PAR-CLIP indicate that HuR binding sites are mostly intronic (Mukherjee et al. 2011) and
individual biochemical examples have identified some HuR binding sequences in exons (Akaike
et al. 2014). HuR binding to CDKN1A intron APA occurs >300bp upstream of the acceptor site
of the alternative APA exon. Additionally, I have not observed a negative correlation between
unspliced and spliced isoforms before or in early UV response, as all stresses and conditions
tested either increase both isoforms, or increase one leaving the other unchanged.
Together, my data suggests that the direct role of HuR is on stability of unspliced
isoform. Although HuR knockdown also appears to increase the levels of the spliced APA
isoform (Figure 21), this can be explained by the initial induction of APA caused by HuR
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knockdown coupled with the long half-life of the spliced isoform (Figure 22). The long half-life of
the spliced APA isoform is a surprising observation, but not completely abnormal, as a number
of lncRNAs have been characterized with half-life of >12 h (Clark et al. 2012). The reasons for
the initial induction of APA after UV treatment during HuR knockdown is not clear but may
reflect an indirect effect caused by the increase in mRNA processing factors levels observed
when HuR levels are low (Mukherjee et al. 2011). Thus, RBP HuR may be a direct binding
partner and regulator of intronic APA isoforms.
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CHAPTER VI
INVESTIGATING THE CELLULAR FUNCTION OF CDKN1A INTRONIC APA TRANSCRIPTS
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Background
Previously, we and others have shown that APA can occur for a specific function from a
particular gene or genome wide to enact a global response (Shi 2012; Lianoglou et al. 2013;
Devany et al. 2016). One such example would be the global reduction in mRNA levels observed
after UV treatment (Cevher and Kleiman 2010), occurring in part due to the reduction in CpA at
canonical 3’ gene ends (Kleiman and Manley 2001) and U1 snRNA-mediated upregulation of
promoter-proximal intronic APA (Devany et al. 2016). The global reduction in mRNA and fulllength transcription is a mechanism that controls gene-expression while the damage is repaired.
The reduction in mRNA levels also reflects a decrease in transcription by RNAP II to avoid its
collision and stalling at intrastrand crosslink lesions, which would affect DNA repair and induce
apoptosis (Arima et al. 2005; Cevher et al. 2008). The idea of competition-as-function makes
sense for APA events, as the levels of transcription for both full-length and APA transcripts are
similar the occurrence of an APA event results in the reduction of the usage of the canonical
poly(A) signal and the levels of those mRNA isoforms. This appears to be the case for the
transmembrane protein Ephrin B2 (Devany et al. 2016), whose alternative poly(A) usage is on
par with canonical poly(A) site usage after DNA damage. Alternatively, APA expression can
occur in negative correlation with the usage of the canonical poly(A), as in the case of IgM
heavy chain (Takagaki et al. 1996), whereby the levels of transcription are not sufficient to drive
expression of both poly(A) isoforms at the same time. Many of APA functions can also be
inferred from protein domains that are truncated due to proximal poly(A) events leading to distal
exon exclusion. Proteins missing domains that also dimerize or oligomerize can also act as
dominant negative isoforms for the expressed full-length versions (Singh et al. 2018). Likewise,
intronic APA leading to retention of certain intronic sequences can extend the open reading
frame from the 5’ exon and add extra amino acid sequences (Movassat et al. 2016).
The picture becomes rather more complicated when the promoter-proximal APA event
occurs in an exon/intron very close to the promoter and omits most of the canonical exons
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resulting in the complete deletion of the coding region. The relevance of promoter-proximal APA
is bolstered by the observation that having long first introns is a general characteristic of
eukaryotic genes (Bradnam and Korf 2008) and that many UV-mediated APA events occur in
the first intron (Devany et al. 2016). Additionally, while the average length of 5’UTR is estimated
to be ~200 nt in humans (Mignone et al. 2002), the average length of exons in the human
genome is ~175 nt (Sakharkar et al. 2004), meaning that in many cases coding regions could
begin in exons downstream of long first introns, which average length could be thousand base
pairs in length, and after APA events. The ultimate outcome of this is a wealth of intragenic
potentially functional lncRNAs produced during DDR, something which has already been
observed (Williamson et al. 2017). Thus, in this Chapter I propose to determine whether the
intragenic lncRNA produced from CDKN1A intronic APA possess functions in different cellular
conditions other than sequestering resources during CDKN1A transcription.

Results

Before I tested the potential function CDKN1A intronic APA isoforms, both unspliced and
spliced, I considered it was important to determine the cellular localization of these isoforms.
RNA from different cellular fractions was obtained from HCT116 cells by lysing the cellular
membranes and leaving the nuclei intact, and RNA was extracted from either the supernatant
(cytoplasm) or the pellet (nuclear) (Hwang et al. 2007; protocol described in Chapter VIII). Both
GAPDH and mature U2 snRNA were used as cellular fraction purification controls, as GAPDH
mRNA is predominantly cytoplasmic and U2 snRNA is predominantly nuclear (Huang and
Pederson 1999). Unfortunately, UV exposure prevented GAPDH from being used as a control
for efficient fractionation, as I observed a nuclear retention following DNA damage (Figure 24).
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Figure 24: Localization of CDKN1A APA isoforms. HCT116 cells were treated
UV irradiation (20 J/m2) and allowed to recover for 2 h before cytoplasmic and
nuclear RNA fractionation. cDNA was synthesized using oligo(dT) primers. RNA
extracted was treated with DNase. qRT-PCR for each CDKN1A isoforms was
performed using primers as depicted in Figures 9A and 11B. U2 snRNA and
GAPDH mRNA (Integrated DNA Technologies) were used as fractionation
control with primers directed towards separate coding exons for forward and
reverse primer to control for possible DNA amplification. Data is presented as the
abundance of RNA detected in the nucleus relative to that detected in the
cytoplasm.

As shown in Figure 24, U2 snRNA was predominantly (~90%) nuclear. As previously
mentioned, GAPDH was mostly cytoplasmic but seemed to undergo a nuclear retention
following UV treatment. Interestingly, CDKN1A full-length mRNA (p21 mRNA in the figure)
showed a similar behavior after UV treatment. This may be due in part to the upstream kinase
ATM’s phosphorylation of an RNA export component, reducing its ability to bind mRNA in the
nucleus (Ramachandran et al. 2011). In terms of APA isoforms, I observed that the unspliced
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transcript was even more predominantly nuclear than mature U2 snRNA, as <0.01% detected
was cytoplasmic. In contrast, the spliced isoform was predominantly cytoplasmic (~ 66%) with
only a small fraction nuclear (~ 33%), and this ratio did not change under stress conditions,
despite its UV-mediated induction. Thus, CDKN1A intronic APA spliced isoform localizes to the
cytoplasm, as the transcript is stable, processed and transported it is unlikely to be a product of
aberrant transcriptional output.
My results on the spliced CDKN1A isoform indicated that transcripts carrying the
alternative exon present in the annotated intron 1 region are polyadenylated, suggesting that the
spliced isoform could be a polyadenylated RNA. However, one possibility is that the qRT-PCR
product analyzed might be from an alternative splicing event to exon 2 of the canonical fulllength CDKN1A mRNA, and thus merely an extension of the 5’UTR (as the coding region of
CDKN1A begins in exon 2). To address this point, I performed a) 3’RACE on the cytoplasmic
and nuclear fractions to determine whether the qPCR data shown in Figure 21 mirror the pattern
of 3’RACE bands (Figure 25), b) qRT-PCR using a forward primer in the APA exon coupled with
a reverse primer in exon 2,and c) analysis of the sequence within and downstream of the
alternative exon generated from splicing/APA of CDKN1A gene for any conserved 5’ splice sites
(Figure 26).
As shown in Figure 25, the 3’RACE mirrored the qPCR data (Figure 24), suggesting that
the spliced APA isoform is predominantly cytoplasmic. Performing qPCR with a forward primer
in the APA exon coupled with a reverse primer in exon 2 produced no amplicon (not shown),
indicating that a splicing event between the APA exon and exon 2 did not occur. Searching for
potential splicing donor site in the APA exon and region downstream using the Human Splicing
Finder software did not find any predicted donor sites (Figure 26; Yeo and Burge 2004).
Together, these studies indicate that the spliced CDKN1A APA transcript is poly(A)+ RNA
enriched in the cytoplasm, and unlikely to be part of the canonical full-length mRNA.
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As the spliced CDKN1A APA lncRNA is a stable transcript that localize in the
cytoplasm (Figures 24, I wonder whether this transcript possess any cellular function. As it is

Figure 25: Nested PCR of 3’RACE to detect CDKN1A spliced APA intronic
isoform. Cytoplasmic and nuclear RNA from HCT116 cells underwent cDNA
synthesis with an adaptor attached to oligo(dT). Amplification was done by 2
rounds of PCR using the adaptor as reverse primer and two different forward
primers within exon 1. Any amplification product could not be priming the poly(A)
of the canonical mRNA as the distance from exon 1 to the canonical poly(A)
would be too large (>2 kbp) for 3’RACE protocol. Thus, only amplification
products at a lower size would represent a poly(A) tail in proximity to exon 1. The
products were separated on an agarose gel and detected by ethidium bromide
staining. A representative gel from three independent assays is shown. Molecular
weight standard (MWS) is also included.
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Figure 26: Analysis of potential donor site strengths within exon 1 and alternative
exon in intron 1 of CDKN1A gene. Sequences were analyzed with the Human
Splicing Finder software and given a MaxEnt score (y-axis). The software
simultaneously analyses adjacent and non-adjacent sequences for the highest
probability for donor and acceptor sites for splicing (Yeo and Burge 2004). A
MaxEnt score above 3 indicates a potential splice site, indicated by the black
line. A) Analysis of the CDKN1A exon 1 sequence, where the known donor site is
indicated as

. B) Analysis of the alternative exon in intron 1 sequence

encompasses the 3’ end of APA exon as well as the intronic sequences ~400 bp
downstream.
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mainly localized in the cytoplasm I foresee a potential effect on the expression levels of some
target proteins affecting a cellular pathway. As the spliced CDKN1A APA transcript was
expressed in positive correlation with CDKN1A full-length mRNA (Figure 18), I hypothesized
that CDKN1A intronic APA may affect the levels of p21 protein expression.

This idea is

supported by previous studies that showed a role for lncRNA with antagonistic function to the
coded protein from the same gene (Williamson et al. 2017). To test this hypothesis, I
overexpressed the spliced CDKN1A intronic transcript in HCT116 cells using the same FLAGtagged plasmid as in Figure 13. I used the empty FLAG-tag expression vector as negative
control. Consistent with previous work (Gottifredi et al. 2001), my results indicate that UV
treatment did not induce full-length CDKN1A mRNA levels (Figure 27). The overexpression of
the spliced APA transcript did also not significantly affect full-length CDKN1A mRNA
abundance. As previously described (Bendjennat et al. 2003; Nishitani et al. 2008), UV
irradiation (20 J/m2) caused a downregulation of p21 protein levels 2 h after the treatment. While
overexpression of spliced CDKN1A intronic APA did not affect p21 protein levels in nonstressed cells, high levels of spliced APA transcript rescued the UV-induced decrease of p21
protein levels (at 2 h recovery after UV treatment). These results suggest that overexpression of
spliced CDKN1A APA transcript may be affecting one of the two mechanism involved in
controlling protein abundance, translation or degradation.
It has been previously described that another CDKN1A-associated lncRNA has
sequence complementarity to certain mRNAs regulating their translation (Yoon et al. 2012).
However, using BLASTn (NCBI) software, I could not find complementary of the CDKN1A APA
lncRNA to the full-length CDKN1A mRNA, nor to any other mRNA (not shown). I use as a
positive control the number of binding sites previously described (Yoon et al. 2012). If the
spliced CDKN1A APA transcript cannot bind to the full-length CDKN1A mRNA or have an effect
on the full-length CDKN1A mRNA levels, it is possible that the transcript is involved in
preventing the p21 protein degradation process, which has been described to occur at
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overlapping time points with UV-induced APA upregulation (Bendjennat et al. 2003). The long
half-life of the spliced isoform
.

Figure 27: Overexpression of spliced CDKN1A APA transcript rescued the UVinduced decrease of p21 protein levels with no effect on full-length CDKN1A
mRNA levels. A) HCT116 cells were transfected with CMV-driven expression
plasmid (10 μg) with N-terminal FLAG tags containing no transcript or spliced
APA transcripts. Total RNA samples were analyzed by qRT-PCR using the
strategy described in Figure 11B. Errors represent the SD derived from three
independent experiments. B) Total protein was extracted from cells transfected
as in A) and immunoassayed with anti-FLAG antibodies. Tubulin was used as
loading control. A representative gel from three independent samples is shown.
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Figure 28: Overexpression of spliced CDKN1A APA transcript increases p21
protein levels after UV treatment but does not prevent p21 degradation. A)
Pattern of p21 levels reduction following CHX treatment (2 μg/ml). Cytoplasmic
proteins were extracted from cells transfected with either control or spliced
plasmid for 24 h as in Figure 27 and immunoassayed with anti-p21 antibodies.
Tubulin was used as loading control. A representative gel from three independent
samples is shown. B) HCT116 cells transfected as in A) were exposed to UV
treatment (20 J/m2) and simultaneously with CHX (2 μg/ml). p53 was used as
marker for UV damage. Samples were analyzed as in A).

(Figure 23) would also allow CDKN1A intron APA transcript to be expressed during p21 protein
recovery time.
Supporting this idea, it has also been shown that lncRNAs can be directly implicated in
ubiquitin ligase-mediated protein degradation (Yoon et al. 2013). To determine whether spliced
CDKN1A APA transcript plays a role in p21 degradation I treated HCT116 cells with
cycloheximide (CHX), which inhibits translation through both prevention of polysome
aggregation as well as chain elongation (Baliga et al. 1969), and analyzed the samples for p21
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expression by Western blot analysis. The rationale was that if protein synthesis was inhibited in
conditions of increased p21degradation and APA induction (UV treatment), I would be able to
measure the effect of APA on the steady-state levels of p21. Interestingly, samples from cells
overexpressing spliced APA transcript showed higher p21 levels than samples from control
(Figure 28). Overexpression of the spliced CDKN1A APA transcript was not able to prevent p21
degradation. It is important to highlight that p21 levels in samples from cells overexpressing
APA transcript and undergoing CHX/UV treatment are much lower than in samples from cells
undergoing only UV treatment (compare lane 9 to 7). The difference in p21 levels was not
observed between CHX/UV and UV treated samples in the control background, suggesting APA
induction may affect a process CHX is affecting.
To further understand the effect of spliced CDKN1A APA transcript on p21 levels, I
decided to perform cellular assays where p21 is known to be involved, such as cell-cycle arrest
(Xiong et al. 1991; Harper et al. 1993) and senescence (Herbig et al. 2004). To test the role of
the APA transcript in cell-cycle arrest I performed flow cytometry on cells transfected with
spliced CDKN1A APA transcript for 24 h and treated with UV irradiation. Cellular DNA content
was detected via propidium iodide after fixing the cells in 100% ethanol. Surprisingly, I did not
see any change in any particular cell cycle stage in the different cells and conditions analyzed
(Figure 29A). I was also not able to detect an addition or reduction of cells in sub-G1, indicating
apoptotic or necrotic cells. This is in contrast with protein expression analysis by Western blot
that showed that overexpression of spliced CDKN1A APA transcript affects the levels of known
markers for apoptosis, such as p21 (Figures 27-28) but also cleaved PARP (Figure 29B).
Overexpression of APA transcript decreased the levels of cleaved PARP after UV treatment
(Boulares et al. 1999; Chaitanya et al. 2010). Thus, the effect of overexpression of this particular
transcript appeared to be limited to early time points after UV, and was perhaps insufficient to
drive a significant cell-cycle arrest.
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Figure 29: Discrepancy between detection of apoptosis markers and FACs analysis
is observed in samples form cells overexpressing spliced CDKN1A APA transcript.
A) Bar graph obtained from cell-cycle analysis of HCT116 cells transfected with
FLAG-tagged plasmids of spliced/unspliced CDKN1A intronic transcript (described in
Figure 13). I used the empty FLAG-tag expression vector as negative control. Flow
cytometry indicating that overexpression does not produce a difference in the
proportion of sub-G1 cells 24 h after UV treatment (20 J/m2). Percentage of cells in
different phases of cell cycle (G1, S, G2m [G2 and mitosis], and apoptosis) are
shown. B) Western blotting for cleaved PARP, a known biomarker for apoptosis
(Boulares et al. 1999), measured in cytoplasmic protein samples from cells
transfected with spliced CDKN1A intronic transcript as described in A) and treated
with UV irradiation (20 J/m2). Protein samples were purified 6 h after the UV
treatment. Samples were immunoassayed with anti-PARP antibodies. Tubulin was
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used as loading control. A representative gel from three independent samples is
shown.
As p21 has been shown to be involved in the induction of senescence (Han et al 2002;
Shtutman et al. 2017) I decided to perform senescence assays in cells overexpressing either
unspliced or spliced CDKN1A APA transcript and treated with etoposide to induce senescence
in growing cells (Litwiniec et al. 2013; Nagano et al. 2016). In Figure 17, my data indicate that
etoposide treatment strongly increases the levels of all the CDKN1A transcripts (unspliced,
spliced and full-length) reaching levels much higher than the observed with UV treatment.
I also used CHX in combination with etoposide to observe if a) CDKN1A spliced intronic
transcript affected p21 expression during a strong upregulation of p21 protein, and b) whether
the inhibition of translation affected any modification of protein levels observed by APA
expression. The data is available in Figure 30. Surprisingly, overexpression of spliced APA
transcript did not appear to have an additive effect of p21 protein induction as had been
observed with UV treatment. Most likely because the effect was negated, As CHX treatment did
not present any difference between the control and the APA overexpression samples, it is
possible that the effect of the spliced APA transcript was negated
I also used a kit based on the detection of senescence-associated β-galactosidase
expressing lysosomes in cells (Debacq-Chainiaux et al. 2009). Cells were fixed to prevent
cellular decomposition and allow visualization of β-galactosidase expression as described in
Chapter VII. Etoposide treatment of non-transfected cells or transfected with empty vector
(Figure 31A) induced a number of blue stained cells (Figure 31A). Quantification is shown in
Figure 31B. However, overexpressing of spliced/unspliced CDKN1A APA transcripts alone or in
combination with etoposide did not have any significant effect on senescence-mediated
pathway. Together, all these negative results led me to look for a simpler and more effective
way of studying the potential functions of CDKN1A APA transcripts.
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Figure 30: Etoposide treatment masks the increase in p21 levels observed with
overexpression of spliced CDKN1A APA transcript (Figures 27 and 28). HCT116
cells were treated with etoposide (20 µM as in Figure 17) or CHX (2 μg/ml as in
Figure 28) as indicated before protein extraction and Western blotting. Total
protein was extracted from cells transfected with either control or spliced plasmid
for 24 h and treated with etoposide for 16 h during transfection time and CHX for
the times indicated in the figure. Samples ran on SDS-PAGE were
immunoassayed with anti-p21 antibodies. GAPDH was used as loading control.
A representative gel from three independent samples is shown.

100

Figure 31: CDKN1A APA isoforms overexpression does not enhance or
suppress etoposide-mediated senescence. A) HCT116 cells were transfected
with CMV-driven expression plasmid containing no transcript (FLAG) or
spliced/unspliced APA transcripts and treated with etoposide (20 µM) for 48 h.
Detection of senescence associated β-galactosidase activity was done using Xgal (Sigma-Aldrich). Cells were observed via phase-contrast microscopy.
Representative images from three independent assays are shown B) Bar graph
represents quantification of percentage of cells counted with positive stain for βgalactosidase activity. Errors represent the SD derived from three independent
experiments.
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The new strategy involved the specific siRNA-mediated knockdown of CDKN1A APA
isoforms. Here, I input the full CDKN1A APA sequence into a program designed by Dharmacon,
which suggested possible siRNA sequences that would be specific, have affinity for APA
transcript, and be thermodynamically viable for use as a complementary oligonucleotide. It was
also of interest to have an siRNA that would target both the spliced and unspliced isoforms to
determine the cellular effect of total APA knockdown. Figure 32A displays the schematic of the
targeting sequence of the siRNA against APA transcripts (siAPA). To identify the function of
lncRNAs,

most

of

the

times,

knockdown/knockout

experiments are

preferred

over

overexpression assays (Yoon et al. 2012; Dimitrova et al. 2014; Williamson et al. 2017).
However, in the case of CDKN1A APA transcript it poses a risk as the the APA sequence is
technically part of the full-length CDKN1A pre-mRNA. While the mechanism for siRNA has been
characterized mostly in the cytoplasm due to the localization of the miRISC complex (Carthew
and Sontheimer 2009), more recent work has identified functional roles for miRNA machinery in
the nucleus (Zhang et al. 2015). In addition, mechanistic studies on siRNA have found it to work
within the nucleus (Castel and Martienssen 2013; Gagnon et al. 2014), and even to work on
pre-mRNA (Bosher et al. 1999). Therefore, to avoid false positive results I tested concentrations
and time points at which CDKN1A APA was significantly affected but not the full-length
CDKN1A mRNA. Figures 32B-C shows the depletion effect of 24 h treatment with siAPA (750
pmols) to a 10 cm plate containing approximately 5 x 106 HCT116 cells. Approximately 50% of
CDKN1A APA transcripts were reduced with not a significant effect on the full-length mRNA,
which was expected as the oligonucleotide targeted the APA exon and thus would target both
unspliced and spliced isoforms but not full-length. Interestingly, a small (5-10%) but not
significant decrease in CDKN1A full-length mRNA abundance was observed. The negative
control GAPDH was not affected by siAPA. Importantly, while siAPA treatment under non-stress
conditions decreased the levels of CDKN1A APA transcripts, these changes in APA transcripts
did not affect the basal levels of CDKN1A full-length mRNA. This is consistent with result
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observed with the overexpression CDKN1A APA transcripts (Figure 27A). Together, these
experiments indicate that siRNA-mediated depletion of CDKN1A APA isoforms can be achieved
without significantly affecting full-length mRNA levels.

Figure 32: siRNA-mediated knockdown of CDKN1A intronic APA isoforms can
be achieved without significantly affecting CDKN1A full-length mRNA levels. A)
Schematic of the target location of siAPA relative in the CDKN1A gene. The
black line represents the location of siRNA, the representation is not to scale. BC) Effect of siAPA treatment for 24 h on levels of CDKN1A intronic APA isoforms
and full-length mRNA. RT-PCR (B) and qRT-PCR (C) results are shown. The
products were separated on an agarose gel and detected by ethidium bromide
staining. A representative gel from three independent assays is shown. Total
RNA samples were analyzed by qRT-PCR using the strategy described in Figure
11B. Errors represent the SD derived from three independent experiments.
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Then I tested whether siRNA-mediated knockdown of CDKN1A intronic APA isoforms
had an effect on p21 protein levels (Figure 33). Intriguingly, the levels of p21 protein were
drastically reduced, particularly in the cytoplasmic fraction. While the nuclear fraction appeared
to undergo an approximately 50% decrease in p21 protein, the cytoplasmic fraction decrease
was around 90%. Then I decided to test whether the decrease in p21 expression by CDKN1A
intronic APA depletion plays a role in cell proliferation. p21 is a strong inhibitor of cellular
proliferation and promotor of differentiation and cellular senescence (Abbas and Dutta 2009).
After HCT116 cells were treated with control or APA siRNA, I performed a cell count every 24 h
to determine the fold change in proliferation. siAPA-mediated knockdown of CDKN1A APA
isoforms led not only to a decrease in p21 levels (Figure 33) but also to an increase in the cell
count compared to siCtrl treated cells (Figure 34), indicating a loss in cell-cycle arrest
capabilities. Finally, to confirm that this effect was p21 specific, I performed the same cell
counting assay on HCT116 p21-/- cells following their antibiotic selection (data shown in Figure
23). No difference in cell count was detected in p21 -/- cells transfected with either siCTLR or
siAPA, suggesting siAPA effect on proliferation is p21 dependent.

Discussion

Most aberrant short and non-polyadenylated RNAs from improper transcription
termination are degraded in the nucleus by the exosome (Vanacova and Stefl 2007). Under
certain conditions mRNAs and polyadenylated RNAs can be degraded in the cytoplasm by the
exosome (Raijmakers et al. 2004). While the mere detection of a spliced CDKN1A APA isoform
primarily in the cytoplasm (Figure 24) does not conclude function it suggests that there might be
one.

The lack of an apparent 5’ss anywhere close to the APA exon (Figure 26) combined with

the 3’RACE mirroring the qPCR data for the spliced CDKN1A APA isoform (Figure 25), and low
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abundance of spliced APA isoform suggest that the alternative splicing event occurs exclusively
on the APA transcript and not on the full-length mRNA. If an alternative splicing event occurred

Figure 33: Knockdown of CDKN1A APA isoforms decreases the level of p21
protein. HCT116 cells were transfected with either control (siCTRL) or APA
siRNA (siAPA) as in Figure 32. Either nuclear (50 ug) or cytoplasmic (15 ug)
protein were analyzed for p21 expression using anti-p21 antibodies. GAPDH
was used as loading control in Western blot analysis. A representative Western
blot from three independent assays is shown.
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Figure 34: Knockdown of APA increases proliferation rate in p21-dependent
manner. A) siAPA treatment of increase HCT116 cells count at a greater fold
change rate than siCTRL treatment. siAPA/siCtrl ratio of the total cell number
counted on hemocytometer for each transfection time is presented. B) After
antibiotic selection (Figure 23), p21-/- cells were transfected for 48 h as
described in (A). Cell number of siAPA treated cells are presented relative to the
number of siCtrl treated cells.

on the CDKN1A full-length transcript, one could expect the expression of an alternative or
truncated protein C-terminus (Lee and Tarn 2014). However, in this event, as in many others
that result from intronic APA events, there is no known protein-coding domain in the CDKN1A
APA isoforms.
The observation that the spliced CDKN1A APA isoform but not the unspliced isoform
localizes in the cytoplasm is not totally surprising. Splicing is often a necessary pre-requisite for
active RNA export from the nucleus (Luo and Reed 1999). The question is whether the
unspliced merely serves as a precursor for the spliced isoform. This seems unlikely based on
the stability of the unspliced form (~3 h half-life, Figure 22), as one would expect a transcript
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whose function is only to be spliced to have very low half-life. However, it is possible that a pool
of unspliced exists ready to be spliced post-transcriptionally. In the context of stability,
surprisingly, the half-life of the spliced CDKN1A APA isoform is very high (>10 h; Figure 22)
comparable to house-keeping gene GAPDH, suggesting a cellular role for this isoform.
While the overexpression data is interesting by itself, it seems to better serve as
confirmation of some of the knockdown data, as the design of the expression vectors may be
flawed. When the CMV-driven expression vectors with either spliced or unspliced APA
transcripts (Figure 13) were designed for translation assays, the cloned sequence began at an
ATG found in exon 1 of CDKN1A full-length mRNA. The ATG in CDKN1A exon1 is not known to
code for protein but instead to suppress translation of p21 protein (Kim et al. 2012; Collier et al.
2018). My data indicate that the presence of this upstream ATG on a separate RNA, such as
the APA isoforms, does not seem to reduce p21 protein levels (Figure 33). As the cloned
sequence begins a the exon 1 ATG, it misses ~30 nt upstream of the ATG not included in the
expression vector for the APA isoforms. If the spliced APA transcript indeed acts as a lncRNA,
its function may be stunted if the first 30 nt of the sequence are missing. This may explain the
negative results observed for cell-cycle, apoptosis and senescence. Therefore, manipulating the
endogenous levels of APA transcript appears to produce more consistent results. However, I
cannot disregard another explanation for these negative results. As discussed in the results
section, it is also possible that overexpression of an abundant lncRNA does not induce a
noticeable change in the cellular function.
The biggest concern for the knockdown experiment is a “off-target” effect. It is important
to determine that changes full-length CDKN1A mRNA abundance are due to the effect of the
lncRNA and not due to siAPA treatment. The role of CDKN1A APA isoform not as a regulator of
the full-length mRNA abundance is support by not only siRNA depletion assays (Figure 32) but
also by the overexpression one (Figure 27) and the proportional changes of the isoforms (Figure
32-33). My results indicate that while the expression of the APA isoforms has not a significant
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effect on the full-length mRNA, it reduced p21 expression levels to <50% of its original pool.
Together, these studies indicate that CDKN1A APA transcripts are regulating levels of the
protein from which it is endogenously made. Having an intragenic transcript capable of
regulating protein levels is an ingenious way for the cell to have another layer of control of
factors involved in highly regulated pathways. What is also interesting is that APA isoforms role
in proliferation depends on the expression of p21, as observed in an isogenic cell line deficient
in p21 (Figure 34). Thus, CDKN1A APA transcripts appear to have roles beyond transcription
competition with the full-length transcript. My data suggest the potential for a feedback loop,
involving p21 protein keeping APA transcripts levels low, while APA maintains p21 protein
levels. Future experiments could investigate this potential by knocking down p21 protein levels
in non-stress conditions to see if APA levels increase.
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CHAPTER VII: FUTURE DIRECTIONS
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Future Directions

CDKN1A gene and p21 regulation has long been studied. The tumor suppressor p21 is
a key CDK inhibitor that negatively regulates cell-cycle progression to prevent aberrant
transmission of damaged DNA to daughter cells. Because of the potent effect of p21 presence
or absence in the cell, the expression of CDKN1A under normal conditions and during DDR is
tightly regulated.
The findings presented in this dissertation show novel features of CDKN1A gene. First,
that CDKN1A undergoes intronic APA during DDR, which is regulated by U1 snRNP (Chapter
III) as a result of endogenous reduction of U1 snRNA levels. Second, that CDKN1A intronic
APA undergoes additional alternative splicing and is a putative lncRNA (Chapter IV).
Furthermore, as part of this dissertation, I described that CDKN1A intronic APA is expressed in
a variety of cell lines and conditions, both cancer and normal cells. CDKN1A intronic APA is
additionally regulated by the RBP HuR (Chapter V). Extending those studies, I also described
that depending on whether CDKN1A intronic APA transcript is spliced or not affects its cellular
localization. Importantly, that intronic APA regulates p21 protein and thus cell proliferation
without affecting CDKN1A full-length mRNA (Chapter VI).
Now, it is important to further elucidate the complete mechanism behind APA-mediated
regulation of p21 protein levels and how APA is regulated outside of global U1 snRNA effect.
Based on my results, I proposed the following model (Figure 35). Under non-stress conditions,
basal levels of both CDKN1A full-length mRNA and intron APA transcript are detected. Under
stress conditions induced by UV or HU treatments, CDKN1A intron APA levels are induced,
which is then spliced and exported from the nucleus to the cytoplasm, where it appears to
possess a role in regulating p21 protein levels. The expression of CDKN1A intron APA probably
plays a role in the degradation/delay in p21 protein induction observed by following UV or HU
treatments (Gottifredi et al. 2001; Bendjennat et al. 2003; Gottifredi et al. 2004).
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Now, it is important to further elucidate the complete mechanism behind APA-mediated
regulation of p21 protein levels and how APA is regulated outside of global U1 snRNA effect.
The following proposed studies might help to understand some aspects of the working model:

Figure 35: Model for CDKN1A intronic APA induction and function. Under nonstress conditions, a default expression of CDKN1A full-length mRNA and protein
occurs. APA is induced weakly, but is necessary for basal p21 protein
expression. Under stress conditions, both CDKN1A full-length mRNA and APA
are induced strongly, where the APA transcript aids in the upregulation of p21
protein levels during DDR.
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Ribosome profiling of CDKN1A intronic APA
The results presented in this dissertation indicate that CDKN1A intronic APA is a
lncRNA, similar to others examples of APA-derived lncRNAs induced after DNA damage
(Williamson et al. 2017). It has been shown that many lncRNAs that localize to the cytoplasm
are associated with ribosomes (Carlevaro-Fita et al. 2016). However, association with the
ribosome is not sufficient to indicate that translation of RNA is taking place (Guttman et al.
2013). The results presented here lay the groundwork for further studies on how APA events
can produce transcripts that are vastly different from the canonical RNAs, and the potential for
these transcripts to be non-coding. My results show that the open reading frame present in
CDKN1A intron APA is not sufficient to produce protein endogenously (Figure 13).
Understanding the ribosome profile of CDKN1A intron APA has the potential to provide
information on the binding to ORFs relative to untranslated regions (UTRs), and thus the coding
potential of a transcript. If CDKN1A indeed associates with ribosomes, one can infer that it
codes for protein if the binding occurs in regions encompassed by ORF. Besides, if association
is determined but that it is not enriched in ORF regions, it suggests that intron APA may be
involved in regulating ribosome-associated processes, such as translation.

Evidence of expression differences of CDKN1A APA isoforms in normal and tumor
tissues from cancer patient
Some expressed lncRNAs have been shown to have oncogenic or tumor suppressor
functions. For example, the lncRNA HOTAIR is highly expressed in a number of different
cancers, with a positive tumorigenic role (Hajjari and Salavaty 2015). While differences in
expression do not directly implicate an RNA as having a role in the transformation process,
some RNAs can also act as biomarkers for a developing cancer (Das et al. 2016).
My data presented in this thesis indicate that CDKN1A intron APA isoform expression
has been detected in a small number of tissue types, both cancer and normal from RNA-seq
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datasets (Figure 16). APA events occurring in a few established cell lines have also been
detected by quantitative PCR (Figure 17). Understanding the expression and inducibility of
CDKN1A intron APA in patient’s tissues, contrasting cancer and normal tissue, will indicate as
whether expression of APA is correlated with an oncogenic or tumor suppressive potential. This
aim is particularly supported by my results that indicate that CDKN1A intronic APA events
positively correlate with as p21 expression, which has been shown to act as both oncogene and
tumor suppressor in different contexts (Abbas and Dutta 2009). In addition, testing whether
CDKN1A intron APA expression also correlates with p21 expression in patient samples will help
to support the data I have obtained in this dissertation.

Determination of additional RBP partners of CDKN1A intron APA transcripts
My studies have shown that CDKN1A intron APA RNA binds directly to RBP HuR under
both non-stress and stress conditions, and transcript stability is regulated by presence of HuR.
Because of these findings, it is likely that HuR plays a direct role in regulating CDKN1A intron
APA transcript stability, and not in the regulation of its potential function in controlling p21
protein levels. Therefore, it is pertinent to identify additional binding partners of intron APA
transcript that may influence intron CDKN1A intron APA RNA function.
On the other hand, studies have shown that lncRNAs expressed during DDR are
capable of binding to transcription factors, such as p53, affecting transcriptional output and thus
cellular response (Puvvula et al. 2014; Schmitt et al. 2016). Independent of transcription,
lncRNAs have been shown to bind and regulate ubiquitin-proteasome pathway by associating
with E3 ligases (Yoon et al. 2013). Therefore, it is possible that protein-binding partners that are
not canonically known to regulate RNA pathways may associate with the CDKN1A intron APA
transcript, resulting in the mutual regulation of their functions.
To find protein binding partners of the CDKN1A intron APA transcript I propose to
perform RNA pull-down assays using a biotinylated APA RNA isoforms and protein extracts as
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detailed in this report when studying HuR (Figure 20). An antisense APA transcript would serve
as ideal negative control transcript. Following incubation with protein extracts, the resultant
eluates from streptavidin-mediated enrichment of RNA-protein complexes will be run on SDSPAGE followed by silver staining to identify proteins pulled-down. Differences in band intensity
between the sense and antisense transcripts would allow the identification of specific protein
binding partners of CDKN1A APA transcript. Proteins will be identified by either massspectrometry of excised bands or estimated via investigative Western blotting based on
molecular weight.

Further characterization of the regulation of p21 protein expression by CDKN1A intron
APA transcript and downstream effects
p21 is regulated by a complex network of pathways dependent on the genetic
background and cellular conditions. For example, p21 transient degradation (Bendjennat et al.
2003) and p21 transcriptional output (Mattia et al. 2007) are regulated under certain stress
conditions and intensities but not others. Because of such curious phenomena, much research
has gone into understanding p21/CDKN1A regulation.
APA offers a new paradigm in p21 regulation, as CDKN1A intron APA transcript
expression appears to be necessary for sustained p21 expression in basal conditions, resulting
in changes in cell growth. To confirm that this effect is not an indirect role of siRNA knockdown,
I propose to create an isogenic knockout cell line that will offer a clear view of CDKN1A intron
APA role in p21 protein abundance. This could be achieved by either deletion of intronic poly(A)
signal or a base change that inactivate it. This cell line will not harbor CDKN1A intron APA but
will possess high conservation for p21 protein. Studying APA in this manner could also address
the question as to whether transcription of the CDKN1A intron APA transcript or its CpA are
involved in the regulation of the CpA of the canonical CDKN1A mRNA.
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Finally, an additional possibility with research potential is to generate knock-in mice,
whereby an intronic poly(A) signal can be incorporated in a region that did not previously harbor
intronic APA (Figure 14A – mouse sequence is similar to Pika), such that CDKN1A intronic APA
transcript could be endogenously expressed. This model will help us to further understand the
role of intron APA in p21 protein regulation and, hence, in cell growth.
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Experimental procedures

Cell lines, plasmids, and treatments
HCT116, HCT116 p21-/-, HCT116 p53 -/-, RKO, RKO-E6, BJ, and MCF7 cells were grown in
Dulbecco’s Modified Eagle Medium (DMEM) without sodium pyruvate and supplemented with
5% fetal bovine serum (FBS) and 1% penicillin/streptomycin antibiotic and harvested at ~90%
confluency after treatments. Mammalian expression vectors were prepared with cDNA of APA
isoforms were cloned into p3xFLAG-CMV10 between EcoRI and BamHI sites. For RNA
pulldown and in vitro translation reactions, cDNA of APA transcripts were cloned into pET42a(+) between Nde1 and Xho1 sites. For UV treatment, 90% confluent cultures were exposed
to UV and harvested at different times. UV doses (20 Jm-2) were delivered in two pulses using a
Stratalinker 1800 (Stratagene). Medium was removed prior to pulsing and cells were washed
with PBS. Media was replaced immediately after treatment. 1.7 mM hydroxyurea (HU) (SigmaAldrich) or 10 µM etoposide (MilliporeSigma) were added directly to media 24 h before
harvesting, except in caffeine experiments where samples were pretreated with 4 mM caffeine
for 1 h (Beckerman et al. 2009; Chen et al. 2011).

Plasmid mutagenesis
To create a mammalian cell expression vector expressing only the unspliced APA isoform, the
full-length APA isoform cloned in p3xFLAG-CMV10 plasmid was subjected to a deletion
mutagenesis of the alternative 3’ splice site present in the sequence in order to express only the
unspliced APA transcript. APA sequence 3’ splice site was deleted using Q5 Site-Directed
Mutagenesis Kit (New England Biolabs) as per the manufacturer’s instructions. Deletion
mutation was achieved using 10 ng of template plasmid and 0.5 µM of forward primer (5’TCCCCACC

CCAAAATGACGCGCAGCC-3’)

and

reverse

primer

(5’-

GGGGGAGAATGGGAGGGG-3’).
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RNA extraction and qRT-PCR assays
Total RNA was purified from approximately 1 x 10⁶ cells using RNeasy Mini Kit (Qiagen). cDNA
was synthesized from 1 g of RNA using either oligo (dT)₁₅ and GoScript reverse transcriptase
(Promega), or qScript cDNA synthesis kit (Quantabio). qPCR was performed using PowerUP
SYBR (Applied Biosystems) in StepOnePlus (ThermoFisher) machine. Relative RNA levels
were calculated using 2-ΔΔCT method (Livak and Schmittgen 2001) and normalized against either
Ubiquitin C (UBC) or β-Actin.

Knockdown expression
siRNA specific for human HuR, a custome-made siRNA for CDKN1A intronic APA and a control
siRNA were obtained from Dharmacon RNA technologies. For HuR knockdown, 60% confluent
cells in 6 well plates were transfected with 5 l of Lipofectamine RNAiMAX according to the
manufacturer’s protocol (Invitrogen) and 200 pmols of siRNA for a total of 36 h. LipofectaminesiRNA complexes were formed in reduced serum Opti-MEM for 5 minutes, during which time
cells to be transfected were washed with warm PBS. Wells to be transfected were incubated
with complete DMEM and Opti-MEM at a 60/40 ratio. To determine the effectiveness and
specificity of HuR siRNA used, protein levels were monitored by Western blot. To knockdown
APA, cells were transfected as for HuR except that 150 pmols of siRNA was used and 3 l of
RNAiMAX for a total of 24 h. Effectiveness and specificity of siAPA was analyzed by qRT-PCR.

RNA stability assay
During transfection of siRNAs, cells at 90% confluency were first treated with UV (20 J/m 2) as
described earlier. After 2 h of recovery time, cells were then treated with 2 µg/ml actinomycin D
into the existing media for the time points indicated (Yoon et al. 2012). After RNA extraction,
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cDNA synthesis and qRT-PCR, analysis was performed by measuring the % remaining RNA
after x number of hours of actinomycin D treatment relative to the amount of RNA detected after
2 h UV treatment.

Cytoplasmic and nuclear RNA extraction
RNA from nuclear and cytoplasmic compartments was extracted essentially as described
(Hwang et al. 2007), with some modification. Instead of subjecting the nuclear pellet and
cytoplasmic supernatant to Trizol reagent, separated samples were put through RNA extraction
kit (Qiagen)

Protein extraction, Western blot analysis and antibodies
After treatments, samples were washed in PBS, scraped, and centrifuged at 4,000 rpm for 10
minutes. Cell pellets were incubated in Buffer A (10 mM Tris pH 7.9, 1.5 mM MgCl₂, 10 mM KCl,
0.5 mM DTT, 0.5 mM PMSF and 100 x Protease Inhibitor Cocktail (PIC; Sigma) for 10 minutes,
prior to douncing 20 times. After centrifugation, cytoplasmic supernatant was extracted.
Remaining pellet was treated with Buffer C (20 mM Tris, 25% glycerol, 1.5 mM MgCl₂, 0.45 M
NaCl, 0.5 mM DTT, 0.5 mM PMSF, and 100 x PIC) and rotated at 4°C for 30 minutes. Samples
were then centrifuged at 13,000 rpm for 15 minutes, and the supernatant was saved as the
nuclear fraction. In most cases, 25 g of protein was analyzed by immunoblotting with mAbs
targeted against p21 (N-20; Devany et al. 2016), PARP (9542; Cell Signalling), HuR (3A2;
(Zhang et al. 2015), FLAG (4GFR; GeneTex), GPD1 (Atlas Antibodies; Menon et al. 2017),
GAPDH (G9; Cell Signalling), or Lamin A (H-102; Fonseca et al. 2018).

Purification of recombinant vectors
To clone plasmids, transformation was performed in DH5α competent cells. Transformations
were completed as per the9 manufacturers instructions (ThermoFisher). To prepare large
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quantities of plasmid (>50 g), transformed bacteria were grown to O.D> 2.5 in 100ml. Plasmid
was extracted via maxiprep according to manufacturers protocol (Qiagen). Plasmids for
mammalian expression utilized the endotoxin removal component of Qiagen kit.

ELISA cell death detection
Cell death was detected with photometric enzyme immunoassay. Known number of cells from 6
well plate wells were diluted in culture medium. Cells were pelleted and sample was treated as
per manufacturer’s instructions (Roche). Once the procedure was run, samples were analyzed
on PowerWave HT Microplate Spectrophotometer (Biotek) (Devany et al. 2013).

3’ RACE
3’RACE was completed using the 3’ RACE System for Rapid Amplification of cDNA ends
(ThermoFisher) as per the manufacturer’s protocol. 1 g of RNA was reverse-transcribed using
oligo(dT)-adaptor primer (5’-GGCCACGCGTCGACTAGTACTTTTTTTTTTTTTTTTT-3’) and
GoScript Reverse Transcriptase (Promega). 1 µl of each cDNA was used for PCR amplification
by

GoTaq

PCR

mix

(Promega)

using

CDKN1A

Exon

1

specific

primer

(5’-

ATGCGTGTTCGCGGGTGT-3’) located 400 bp upstream of poly(A) site and adaptor (5’GGCCACGCGTCGACTAGTAC 3’). For nested PCR, a second CDKN1A specific forward
primer in APA exon was used (5’-AGCCGGAGTGGAAGCAGA-3’) and the same adaptor. PCR
products were separated in 1.5% agarose gel and the gels were stained with 0.2 mg/ml
ethidium bromide embedded in the gel. Bands were visualized using DyNA Light UV
Transilluminator.
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Protein translation assays
For FLAG-tagged APA expression, cDNA of APA transcripts were overexpressed and
immunoblotted against FLAG. For in vitro translation reactions, we used the Transcend NonRadioactive Translation Detection System (Promega) as per the manufacturer’s instructions.
Equivalent

amounts

of

sample

were

then

run

on

SDS-PAGE

and

analyzed

by

chemiluminescence following a reaction of Lysine-biotin bound streptavidin-HRP to the
substrate.

RNA immunoprecipitation
Protein A magnetic beads (Pierce) were washed with 1ml PBS containing 0.1% Tween-20 and
vortexed vigorously for 10 seconds. Buffer was removed and 600 l of new PBS-T was added
as well as 1 g of recombinant HuR protein. Samples were incubated and mixed for 30 minutes
at room temperature, followed by 3 x wash in PBS-T using magnetic rack (Millipore). 1 g of
total RNA was then added and sample was incubated for 3 h at 4ºC with rotation. Sample was
washed 3 x in PBS-T before phenol chloroform extraction and qRT-PCR (Zhang et al. 2015).

RNA pull-down
T7-driven pet42a plasmid containing APA transcript cDNA was used as template for in vitro
transcription using RNA Biotin Labelling Mix (Sigma) and T7 polymerase (Promega).
Biotinylated RNA was purified by ethanol precipitation and mixed with 1 mg protein extract
overnight at 4°C. RNA-protein mixture was then incubated with 50 μl washed magnetic
streptavidin beads (ThermoFisher) for 1 h prior to 5 times wash with Buffer A + 500 mM NaCl,
suspending in 2X Laemmli buffer and heating at 95°C before SDS-PAGE and immunoassays.
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Flow cytometry
HCT116 cells at ~60% confluency at 2 x 6 well plate wells/sample were transfected and/or
damaged by UV (20 J/m2) as described earlier. After 24 hours, cells were washed with ice-cold
PBS and scraped using plastic cell scraper. Cells were then pelleted at 750 rcf for 7.5 mins at
4ºC. Cell pellets were resuspended in 1ml of ice-cold PBS and added drop-wise to pre-cooled
100% ethanol with gentle vortexing to fix. Fixed cells were left at -30ºC for 12-24 h before
centrifuging to pellet. Pellets were resuspended in 400ul of staining mixture consisting of 0.1%
Triton X-100, 2 mg RNAse A and 20 µg/ml propidium iodide. Cells were then strained using
40µm mesh into polystyrene tubes and incubated at room temperature for 30 minutes. Samples
were then stored on ice away from light and analysed on FACSCalibur Flow Cytometer (BD
Biosciences).

Senescence Assay
To detect senescence-associated β-galactosidase activity, the ‘senescence cells histochemical
staining kit’ (Sigma Aldrich) was used. HCT116 cells were grown to ~50% confluency prior to
etoposide and/or plasmid expression for 48 h. Treated cells at ~90% confluency were fixed and
stained as per the manufacturers instructions. Samples were incubated at 37ºC and monitored
for approximately 6 hours to obtain maximum signal. Images were taken at 30x magnification
with phase-contrast microscope.
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Primers
Primer Name
U2 snRNA Forward

Sequence (5’ – 3’)
GGCCTTTTGGCTAAGATCAA

U2 snRNA Reverse

TATTCCATCTCCCTGCTCCA

p21 Exon 2 Forward

CTGGAGACTCTCAGGGTCGAAA

p21 Exon 3 Reverse

GATTAGGGCTTCCTCTTGGAGAA

HuR Forward

CAGAAGAGGCAATTACCAGTTTCAATGG

HuR Reverse

GCTTCTTCATAGTTTGTCATGGTCAC

Actin Exon 3 Forward

GCATCCTGACCCTCAAGTACCC

Actin Exon 4 Reverse

TAGCACAGCTTCTCCTTGATGTCC

CDKN1A Exon 1 Forward

ATGCGTGTTCGCGGGTGT

CDKN1A APA Exon Reverse

AGTGATGAGTCAGTTTCCTGCAAG

CDKN1A APA Exon Forward

AGCCGGAGTGGAAGCAGA

CDKN1A Intron 1 Forward

GGCGGAGAGCGGGATTACAAGT

CDKN1A Intron 1 Reverse

AGGTGGTGGACACAGTGGCGTA

p53 3’UTR Long Forward

Ubiquitin C Forward

AGCCGCATTAACCCTCACTAAA
-GGGACATTCTCCACTTCTTGTT
GGAATAAGCTTAAAAAAAAAAAAA
-AAAAATGGGATATAAAAAGGG
TGGCACAGCTAGTTCCGTCGCA

Ubiquitin C Reverse

CGAGGGTGATGGTCTTACCAGTC

GAPDH Forward

ACCACAGTCCATGCCATCAC

GAPDH Reverse

TCCACCACCCTGTTGCTGTA

E2F1 Exon 1 Forward
E2F1 Intron 1 Reverse
E2F1 Exon 2 Reverse
DSCR3 Exon 1 Forward
DSCR3 Intron 1 Reverse
DSCR3 Exon 2 Reverse
NOTCH1 3’UTR Forward
NOTCH1 Proximal Reverse
NOTCH1 Distal Reverse
KDELR1 3’UTR Forward
KDELR1 3’UTR Proximal Reverse
KDELR1 3’UTR Distal Reverse
DUSP6 Forward
DUSP6 Proximal Reverse
DUSP6 Distal Reverse
SNRNPB2 Forward
SNRNPB2 Proximal Reverse
SNRNPB2 Distal Reverse

TGACCTGCTGCTCTTCGCCACA
CTGGCTTGAAGTCGCCCAAAG
GTCAGTTTCCAGGTCCAGCCT
GGACCGCCCTGGACATCAAGAT
TCAAGGGGCCAGATGGGAAGAG
GTTACCCTTCAAGTGCAGAGG
AACGTCTCCGACTGGTCCGA
TGGCATCCACAGAGCGCACACAGA
GAAGGTGAGCCAGCTTTGCCT
GGAAGGCGGCAGAAGATGAAGAG
CAAGACCTGGATCCTCCACTG
GATGGGTGTCGGCAGATTTAGTG
ACACCAAATCATGGGCTCACTT
GAGGTGACACTCCCTGAAGAAT
CCTTGCCCTACTATGCCTACAA
TAATCAGTTCCCTGGCTTCAAGG
CACCAAGGCTAAAGAAACACTGG
GATGATAGGGAGATGGGTCAATC

p53 3’UTR Long Reverse
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